KR101556819B1 - Organic compounds and organic electro luminescence device using the same - Google Patents

Organic compounds and organic electro luminescence device using the same Download PDF

Info

Publication number
KR101556819B1
KR101556819B1 KR1020120118638A KR20120118638A KR101556819B1 KR 101556819 B1 KR101556819 B1 KR 101556819B1 KR 1020120118638 A KR1020120118638 A KR 1020120118638A KR 20120118638 A KR20120118638 A KR 20120118638A KR 101556819 B1 KR101556819 B1 KR 101556819B1
Authority
KR
South Korea
Prior art keywords
group
inv
synthesis
mol
organic
Prior art date
Application number
KR1020120118638A
Other languages
Korean (ko)
Other versions
KR20140052499A (en
Inventor
백영미
김성무
이용환
박호철
이창준
신진용
김태형
Original Assignee
주식회사 두산
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 두산 filed Critical 주식회사 두산
Priority to KR1020120118638A priority Critical patent/KR101556819B1/en
Priority to PCT/KR2013/007955 priority patent/WO2014065501A1/en
Publication of KR20140052499A publication Critical patent/KR20140052499A/en
Application granted granted Critical
Publication of KR101556819B1 publication Critical patent/KR101556819B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • C07F9/5022Aromatic phosphines (P-C aromatic linkage)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05BELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B33/00Electroluminescent light sources
    • H05B33/12Light sources with substantially two-dimensional radiating surfaces
    • H05B33/14Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the electroluminescent material, or by the simultaneous addition of the electroluminescent material in or onto the light source
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/341Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/342Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/40Organosilicon compounds, e.g. TIPS pentacene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/622Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/658Organoboranes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1096Heterocyclic compounds characterised by ligands containing other heteroatoms
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K2101/00Properties of the organic materials covered by group H10K85/00
    • H10K2101/10Triplet emission

Abstract

본 발명은 하기 화학식 1로 표시되는 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것으로서, 하기 화학식 1로 표시되는 화합물을 하나 이상의 유기물층, 바람직하게는 발광층에 포함함으로써, 소자의 발광효율, 구동 전압, 수명 등이 유의적으로 향상될 수 있다.The present invention relates to a compound represented by the following general formula (1) and an organic electroluminescent device including the same, wherein the compound represented by the following general formula (1) is contained in at least one organic layer, preferably a light emitting layer, Life and the like can be significantly improved.

Description

유기 화합물 및 이를 포함하는 유기 전계 발광 소자{ORGANIC COMPOUNDS AND ORGANIC ELECTRO LUMINESCENCE DEVICE USING THE SAME}TECHNICAL FIELD [0001] The present invention relates to an organic compound and an organic electroluminescent device including the organic compound.

본 발명은 유기 전계 발광 소자용 재료로서 사용될 수 있는 신규 유기 화합물 및 이를 포함하여 소자의 발광효율, 구동전압, 수명 등이 향상되는 유기 전계 발광 소자에 관한 것이다.
The present invention relates to a novel organic compound which can be used as a material for an organic electroluminescent device, and an organic electroluminescent device including the same, which improves the luminous efficiency, driving voltage and lifetime of the device.

유기 전계 발광(electroluminescent, EL) 소자(이하, 간단히 '유기 EL 소자'로 칭함)에 대한 연구는 1950년대 Bernanose의 유기 박막 발광 관측을 시점으로 1965년 안트라센 단결정을 이용한 청색 전기발광으로 이어졌으며, 비로소 1987년 탕(Tang)에 의하여 정공층과 발광층의 기능층으로 나눈 적층 구조의 유기 EL 소자가 제시되었다. 이후, 고효율, 고수명의 유기 EL 소자를 만들기 위하여, 소자 내 각각의 특징적인 유기물 층을 도입하는 형태로 발전하여 왔으며, 이에 사용되는 특화된 물질의 개발로 이어졌다. The study of organic electroluminescent (EL) devices (hereinafter simply referred to as 'organic EL devices') led to blue electroluminescence using anthracene single crystals in 1965 based on observations of organic thin films from Bernanose in the 1950s. In 1987, a layered organic EL device was proposed by Tang divided into a hole layer and a functional layer of a light emitting layer. Thereafter, in order to make a high efficiency and high number of organic EL devices, each organic EL device has been developed in a manner of introducing each characteristic organic material layer in the device, leading to the development of specialized materials used therefor.

유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 이때, 유기물층으로 사용되는 물질은 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다. In the organic electroluminescent device, when a voltage is applied between two electrodes, holes are injected into the anode, and electrons are injected into the organic layer from the cathode. When the injected holes and electrons meet, an exciton is formed. When the exciton falls to the ground state, light is emitted. The material used as the organic material layer may be classified into a light emitting material, a hole injecting material, a hole transporting material, an electron transporting material, and an electron injecting material depending on functions.

발광 물질은 발광색에 따라 청색, 녹색, 적색 발광 물질과 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색 발광 물질로 구분될 수 있다. 또한, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여, 발광 물질로서 호스트/도판트 계를 사용할 수 있다.The luminescent material can be classified into blue, green and red luminescent materials according to luminescent colors and yellow and orange luminescent materials necessary for realizing better natural colors. Further, in order to increase the color purity and to increase the luminous efficiency through energy transfer, a host / dopant system can be used as a luminescent material.

도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 이때, 인광 재료의 개발은 이론적으로 형광에 비해 4배까지의 발광 효율을 향상시킬 수 있기 때문에, 인광 도판트 뿐만 아니라 인광 호스트 재료들에 대한 연구가 많이 진행되고 있다.The dopant material can be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. At this time, since the phosphorescent material can theoretically improve the luminous efficiency up to 4 times as compared with the fluorescent material, researches on phosphorescent host materials as well as phosphorescent dopants have been conducted.

현재까지 정공 주입층, 정공 수송층, 정공 차단층, 전자 수송층으로는 NPB, BCP, Alq3 등이 널리 알려져 있으며, 발광 재료로는 안트라센 유도체들이 형광 도판트/호스트 재료로서 보고되고 있다. 특히, 발광 재료 중 효율 향상 측면에서 큰 장점을 가지고 있는 인광 재료들은 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물이 청색(blue), 녹색(green), 적색(red) 도판트 재료로 사용되고 있으며, 현재까지는 CBP가 인광 호스트 재료로 높은 특성을 나타내고 있다.Until now, NPB, BCP, and Alq 3 have been widely known as a hole injecting layer, a hole transporting layer, a hole blocking layer, and an electron transporting layer. Anthracene derivatives as a light emitting material have been reported as fluorescent dopant / host materials. In particular, the phosphor has a great advantage in improving the efficiency aspects of the light-emitting material materials Firpic, Ir (ppy) 3, (acac) Ir (btp) 2 Ir metal complex compound is blue (blue), which includes the same as the green ( green and red dopant materials, and CBP is a phosphorescent host material.

그러나 기존의 재료들은 발광 특성 측면에서는 유리한 면이 있으나, 유리전이온도가 낮고 열적 안정성이 매우 좋지 않아 OLED 소자에서의 수명 측면에서 만족할 만한 수준이 되지 못하는 실정이다. 따라서 더욱 성능이 뛰어난 재료의 개발이 요구되고 있다.
However, existing materials have advantages in terms of light emitting properties, but they are not satisfactory in terms of lifetime in OLED devices because of low glass transition temperature and poor thermal stability. Therefore, development of materials with higher performance is required.

본 발명은 높은 유리 전이온도로 인해 열적 안정성이 우수하면서, 정공과 전자의 결합력을 향상시킬 수 있는 신규 유기 화합물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a novel organic compound capable of improving the bonding force between holes and electrons while having excellent thermal stability due to a high glass transition temperature.

또한, 본 발명은 상기 신규 유기 화합물을 포함하여 구동전압, 발광효율 등이 향상된 유기 전계 발광 소자를 제공하는 것을 목적으로 한다.
It is another object of the present invention to provide an organic electroluminescent device including the novel organic compound and having improved driving voltage, luminescent efficiency and the like.

본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다.The present invention provides a compound represented by the following formula (1).

Figure 112012086902721-pat00001
Figure 112012086902721-pat00001

상기 화학식 1에서,In Formula 1,

R6 및 R7 또는 R7 및 R8 중 적어도 하나는 하기 화학식 2와 축합 고리를 형성하고,R 6 and R 7 or R 7 and R 8, at least one of which is to form the formula (2) with a condensed ring,

Figure 112012086902721-pat00002
Figure 112012086902721-pat00002

상기 화학식 2에서,In Formula 2,

X는 O, S, Se, N(Ar2), C(Ar3)(Ar4), Si(Ar5)(Ar6), P(Ar7) 및 B(Ar8)로 구성된 군으로부터 선택되고, X is O, S, Se, N ( Ar 2), C (Ar 3) (Ar 4), Si (Ar 5) (Ar 6), P selected from the group consisting of (Ar 7) and B (Ar 8) And,

R1 내지 R12 는 서로 같거나 또는 상이하고, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 니트로, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C6~C60의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 60의 헤테로아릴기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C60의 아릴옥시기, 치환 또는 비치환된 C3~C40의 알킬실릴기, 치환 또는 비치환된 C6~C60의 아릴실릴기, 치환 또는 비치환된 C2~C40의 알킬보론기, 치환 또는 비치환된 C6~C60의 아릴보론기, 치환 또는 비치환된 C6~C60의 아릴포스핀기, 치환 또는 비치환된 C6~C60의 아릴포스핀옥사이드기, 및 치환 또는 비치환된 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 이들은 인접하는 기와 결합하여 축합 고리를 형성할 수 있으며, R 1 to R 12 are the same or different and each independently represents hydrogen, deuterium, halogen, cyano, nitro, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 2 to C 40 A substituted or unsubstituted C 2 to C 40 alkynyl group, a substituted or unsubstituted C 3 to C 40 cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40 nucleus atoms, a substituted or unsubstituted C 2 to C 40 alkynyl group, An unsubstituted C 6 to C 60 aryl group, a substituted or unsubstituted heteroaryl group having 5 to 60 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkyloxy group, a substituted or unsubstituted C 6 ~ C 60 of the aryloxy group, a substituted or unsubstituted C 3 ~ C 40 alkyl silyl group, a substituted or arylsilyl unsubstituted C 6 ~ C 60 group, a substituted or unsubstituted C 2 ~ C 40 alkyl boron group, a substituted or unsubstituted C 6 ~ C 60 aryl group of boron, a substituted or unsubstituted C 6 ~ C 60 aryl phosphine group, a substituted or unsubstituted C 6 ~ C 60 aryl phosphine oxide group is selected from the pin, and the group consisting of a substituted or unsubstituted C 6 ~ C 60 aryl amine, these are combined tile adjacent may form a condensed ring,

Ar1 내지 Ar8 은 서로 같거나 또는 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 니트로, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C6~C60의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 60의 헤테로아릴기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C60의 아릴옥시기, 치환 또는 비치환된 C3~C40의 알킬실릴기, 치환 또는 비치환된 C6~C60의 아릴실릴기, 치환 또는 비치환된 C2~C40의 알킬보론기, 치환 또는 비치환된 C6~C60의 아릴보론기, 치환 또는 비치환된 C6~C60의 아릴포스핀기, 치환 또는 비치환된 C6~C60의 아릴포스핀옥사이드기, 및 치환 또는 비치환된 C6~C60의 아릴아민기로 구성된 군으로부터 선택되며, Ar 1 to Ar 8 are the same or different and each independently represents hydrogen, deuterium, halogen, cyano, nitro, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 2 to C 40 A substituted or unsubstituted C 2 to C 40 alkynyl group, a substituted or unsubstituted C 3 to C 40 cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40 nucleus atoms, a substituted or unsubstituted C 2 to C 40 alkynyl group, An unsubstituted C 6 to C 60 aryl group, a substituted or unsubstituted heteroaryl group having 5 to 60 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkyloxy group, a substituted or unsubstituted C 6 ~ C 60 of the aryloxy group, a substituted or unsubstituted C 3 ~ C 40 alkyl silyl group, a substituted or arylsilyl unsubstituted C 6 ~ C 60 group, a substituted or unsubstituted C 2 ~ C 40 alkyl A boron group, a substituted or unsubstituted C 6 to C 60 arylboron group, a substituted or unsubstituted C 6 to C 60 arylphosphine group, a substituted or unsubstituted aryl group, Substituted C 6 to C 60 aryl phosphine oxide groups, and substituted or unsubstituted C 6 to C 60 arylamine groups,

상기 R1~R12 및 Ar1~Ar8에서, '치환 또는 비치환된'이라는 용어가 기재된 치환기, 일례로 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기, 아릴아민기는, 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C6~C40의 아릴실릴기, C2~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기, 및 C6~C60의 아릴아민기로 이루어진 군으로부터 선택되는 하나 이상의 치환기로 치환될 수 있다. 이때 복수 개의 치환기가 도입되는 경우, 이들 치환기는 서로 동일하거나 또는 상이할 수 있다.In R 1 to R 12 and Ar 1 to Ar 8 , the substituent described in the term "substituted or unsubstituted", for example, an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, , alkyloxy, aryloxy of time, an alkyl boron group, an aryl boron group, an aryl phosphine group, aryl phosphine oxide group, an arylamine group, each independently selected from deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 An alkyl group, a C 2 to C 40 alkenyl group, a C 2 to C 40 alkynyl group, a C 6 to C 40 aryl group, a heteroaryl group having 5 to 40 nuclear atoms, a C 6 to C 40 aryloxy group, A C 1 to C 40 alkyloxy group, a C 6 to C 40 arylamine group, a C 3 to C 40 cycloalkyl group, a heterocyclic cycloalkyl group having 3 to 40 nuclear atoms, a C 1 to C 40 alkylsilyl group, C 6 ~ C 40 aryl silyl group, C 2 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide Group, and C 6 With one or more substituents selected from the group consisting of arylamine ~ C 60 can be replaced. When a plurality of substituents are introduced at this time, these substituents may be the same as or different from each other.

또한, 본 발명은 (i) 양극, (ⅱ) 음극, 및 (ⅲ) 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자를 제공한다.The present invention also provides an organic electroluminescent device comprising at least one organic material layer interposed between (i) an anode, (ii) a cathode, and (iii) an anode and a cathode, wherein at least one of the one or more organic layers One is an organic electroluminescent device comprising a compound represented by the general formula (1).

여기서, 상기 1층 이상의 유기물층 중 적어도 하나는 정공 주입층, 정공 수송층 및 발광층으로 구성된 군으로부터 선택될 수 있으며, 발광층인 것이 바람직하다. 이때, 상기 화학식 1로 표시되는 화합물은 청색, 녹색 또는 적색의 인광 호스트 재료이다.
At least one of the one or more organic layers may be selected from the group consisting of a hole injecting layer, a hole transporting layer, and a light emitting layer, and is preferably a light emitting layer. At this time, the compound represented by Formula 1 is a blue, green or red phosphorescent host material.

본 발명의 화학식 1 로 표시되는 신규 화합물은 열적 안정성 및 인광 특성이 우수하기 때문에, 유기 전계 발광 소자의 발광층에 적용될 수 있다.The novel compounds represented by the formula (1) of the present invention are excellent in thermal stability and phosphorescence properties and thus can be applied to a light emitting layer of an organic electroluminescent device.

따라서, 본 발명의 화학식 1로 표시되는 화합물을 인광 호스트 물질로 사용할 경우, 종래 호스트 물질에 비해 우수한 발광 성능, 낮은 구동전압, 높은 효율 및 장수명을 갖는 유기 전계 발광 소자를 제조할 수 있고, 나아가 성능 및 수명이 크게 향상된 풀 칼라 디스플레이 패널을 제조할 수 있다.
Accordingly, when the compound represented by Formula 1 of the present invention is used as a phosphorescent host material, it is possible to manufacture an organic electroluminescent device having excellent light emitting performance, low driving voltage, high efficiency and long life time as compared with the conventional host material, And a full color display panel having a greatly improved lifetime can be manufactured.

이하, 본 발명을 상세히 설명한다.
Hereinafter, the present invention will be described in detail.

<신규 화합물><Novel compound>

본 발명은 종래 유기 EL 소자용 재료 [예: 4,4-dicarbazolybiphenyl (이하, 'CBP'로 표시함)] 보다 분자량이 클 뿐만 아니라, 넓은 에너지 밴드갭을 가지면서, 정공과 전자의 결합력을 높일 수 있는 상기 화학식 1로 표시되는 화합물을 제공하는 것을 특징으로 한다. The present invention has a higher molecular weight than a conventional organic EL device material (for example, 4,4-dicarbazolybiphenyl (hereinafter referred to as 'CBP')), and has a wide energy bandgap while enhancing the bonding force between holes and electrons The compound represented by the above formula (1).

본 발명에 따라 상기 화학식 1로 표시되는 신규 화합물은, 카바졸(carbazole) 기본 골격에 인돌기(indole)가 융합되어 있으며, 여기에 여러 치환체에 의해 에너지 레벨이 조절됨으로써, 넓은 밴드갭 (sky blue ~ red)을 갖게 된다. 이러한 화합물을 유기 EL 소자에 이용할 경우, 소자의 인광 특성을 개선함과 동시에 정공 주입 능력 및/또는 수송 능력, 효율(발광효율, 전력효율), 구동전압, 수명 특성, 휘도 등이 개선될 수 있다. 따라서, 발광층 뿐만 아니라 여러 치환체의 도입으로 인해 정공 수송층, 정공 주입층 등으로도 응용될 수 있다. 특히, 상기 화합물은 카바졸 기본 골격에 인돌기가 융합되어 있는 구조적 특이성으로 인해, 넓은 밴드갭을 가지면서 정공과 전자의 결합력을 높일 수 있기 때문에, 종래 CBP에 비해 발광층의 호스트 재료로서의 우수한 특성을 나타낼 수 있다.According to the present invention, the novel compound represented by Formula 1 has indole fused to a carbazole basic skeleton, and its energy level is controlled by various substituents. Thus, a broad band gap (sky blue ~ red). When such a compound is used in an organic EL device, the phosphorescent property of the device can be improved and the hole injecting ability and / or transporting ability, efficiency (luminous efficiency, power efficiency), driving voltage, lifetime characteristics, . Therefore, the present invention can be applied not only to a light emitting layer but also to a hole transporting layer, a hole injecting layer, etc. due to the introduction of various substituents. Particularly, since the compound has a wide band gap and can increase the bonding force between holes and electrons due to the structural specificity that the indole group is fused to the carbazole basic skeleton, the compound exhibits excellent characteristics as a host material of the light emitting layer compared to CBP .

또한, 인돌기가 융합된 카바졸 기본 골격에, 다수 도입된 다양한 방향족 환(aromatic ring) 치환체로 인해 화합물의 분자량이 유의적으로 증대됨으로써, 유리전이온도가 향상되고, 이로 인해 종래 CBP 보다 높은 열적 안정성을 가질 수 있다. In addition, since the molecular weight of the compound is significantly increased due to various aromatic ring substituents introduced into the carbazole basic skeleton in which the indole group is fused, the glass transition temperature is improved and the thermal stability Lt; / RTI &gt;

아울러 본 발명의 신규 화합물은, 카바졸 환 내부에 사이클로헥실이 융합됨으로써, 화합물의 열안정성 향상이 도모되고, 그 화합물을 포함하는 유기막의 안정성, 결정화 억제 면에서도 효과가 있다. 따라서, 본 발명의 화합물을 포함하는 유기 EL 소자는 내구성 및 수명 특성을 크게 향상시킬 수 있다. In addition, the novel compound of the present invention is improved in the thermal stability of the compound by fusing cyclohexyl inside the carbazole ring, and is also effective in stability and inhibition of crystallization of the organic film containing the compound. Therefore, the organic EL device comprising the compound of the present invention can greatly improve durability and lifetime characteristics.

추가적으로, 본 발명에 따른 화학식 1의 화합물을 유기 EL 소자의 정공 주입/수송층, 청색, 녹색 및/또는 적색의 인광 호스트 재료로 채택할 경우, 종래 CBP 대비 효율 및 수명 면에서 월등히 우수한 효과를 발휘할 수 있다. 따라서, 본 발명에 따른 화합물은 유기 EL 소자의 성능 개선 및 수명 향상에 크게 기여할 수 있으며, 특히 이러한 소자의 수명 향상은 풀 칼라 유기 발광 패널에서의 성능 극대화에도 큰 효과가 있다.In addition, when the compound of Formula 1 according to the present invention is used as a positive hole injection / transport layer, a blue, green, and / or red phosphorescent host material of an organic EL device, have. Therefore, the compound according to the present invention can greatly contribute to improvement of the performance and lifetime of the organic EL device, and in particular, the lifetime improvement of such a device has a great effect on maximizing the performance in the full-color organic light emitting panel.

본 발명에 따른 화학식 1로 표시되는 화합물에서, 상기 화학식 2와 축합고리를 형성하는 치환기, 일례로 R6와 R7 및/또는 R7와 R8을 제외하는 R1 내지 R12는 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 니트로, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C6~C60의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 60의 헤테로아릴기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C60의 아릴옥시기, 치환 또는 비치환된 C3~C40의 알킬실릴기, 치환 또는 비치환된 C6~C60의 아릴실릴기, 치환 또는 비치환된 C2~C40의 알킬보론기, 치환 또는 비치환된 C6~C60의 아릴보론기, 치환 또는 비치환된 C6~C60의 아릴포스핀기, 치환 또는 비치환된 C6~C60의 아릴포스핀옥사이드기, 및 치환 또는 비치환된 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 이들은 인접하는 기와 결합하여 축합 고리를 형성할 수 있다.In the compound represented by the general formula (1) according to the present invention, the substituent forming the condensation ring with the general formula (2), for example, R 6 and R 7 and / or R 1 to R 12 excluding R 7 and R 8 are the same Substituted or unsubstituted C 1 to C 40 alkyl, substituted or unsubstituted C 2 to C 40 alkenyl, substituted or unsubstituted C &lt; RTI ID = 0.0 &gt; of 2 ~ C 40 alkynyl group, a substituted or unsubstituted C 3 ~ C 40 cycloalkyl group, a substituted or unsubstituted nucleus atom to C40 heterocycloalkyl group, a substituted or unsubstituted C 6 ~ C 60 of the aryl A substituted or unsubstituted C 1 -C 40 alkyloxy group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted heteroaryl group having 5 to 60 ring atoms, the unsubstituted C 3 ~ C 40 alkylsilyl group, a substituted or unsubstituted C 6 ~ C 60 aryl silyl group, a substituted addition Unsubstituted C 2 ~ C 40 alkyl boron group, a substituted or unsubstituted C with 6 ~ C 60 aryl boron group, an aryl phosphonic a substituted or unsubstituted C 6 ~ C 60 ring pingi of, substituted or unsubstituted C 6 of ~ C 60 aryl phosphine oxide group is selected from the pin, and the group consisting of a substituted or unsubstituted C 6 ~ C 60 aryl amine, these are combined tile adjacent to form a condensed ring.

이때, R6와 R7 및/또는 R7와 R8을 제외하는 R1 내지 R12는 수소, 치환 또는 비치환된 C6~C60의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 60의 헤테로아릴기인 경우가 바람직하다.Here, R 1 to R 12 , excluding R 6 and R 7 and / or R 7 and R 8 , represent hydrogen, a substituted or unsubstituted C 6 to C 60 aryl group, a substituted or unsubstituted five to twenty- Lt; RTI ID = 0.0 &gt; of-60 &lt; / RTI &gt;

한편, 상기 화학식 2에서, 상기 점선은 화학식 1의 화합물과 축합이 이루어지는 부위를 의미한다.In the formula (2), the dotted line indicates a site where condensation is performed with the compound of formula (1).

본 발명에 따른 화학식 2에서, X는 O, S, Se, N(Ar2), C(Ar3)(Ar4), Si(Ar5)(Ar6), P(Ar7) 및 B(Ar8)로 구성된 군에서 선택되며, 바람직하게는 O, S, N(Ar2), C(Ar3)(Ar4)에서 선택될 수 있으며, 더욱 바람직하게는 N(Ar2)이다. In general formula [2] according to the present invention, X is O, S, Se, N ( Ar 2), C (Ar 3) (Ar 4), Si (Ar 5) (Ar 6), P (Ar 7) and B ( Ar 8 ), preferably O, S, N (Ar 2 ), C (Ar 3 ) (Ar 4 ), and more preferably N (Ar 2 ).

상기 화학식 2에서, Ar1 내지 Ar8 은 서로 같거나 또는 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 니트로, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된C2~C40의 알케닐기, 치환 또는 비치환된C2~C40의 알키닐기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C6~C60의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 60의 헤테로아릴기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C60의 아릴옥시기, 치환 또는 비치환된 C3~C40의 알킬실릴기, 치환 또는 비치환된 C6~C60의 아릴실릴기, 치환 또는 비치환된 C2~C40의 알킬보론기, 치환 또는 비치환된 C6~C60의 아릴보론기, 치환 또는 비치환된 C6~C60의 아릴포스핀기, 치환 또는 비치환된 C6~C60의 아릴포스핀옥사이드기, 및 치환 또는 비치환된 C6~C60의 아릴아민기로 구성된 군으로부터 선택될 수 있다. In the general formula (2), Ar 1 to Ar 8 are the same or different and each independently represents hydrogen, deuterium, halogen, cyano, nitro, a substituted or unsubstituted C 1 to C 40 alkyl group, C 2 ~ C 40 alkenyl group, a substituted or unsubstituted C 2 ~ C 40 of the alkynyl group, a substituted or unsubstituted C 3 ~ C 40 cycloalkyl group, a substituted or unsubstituted nucleus of atoms of 3 to 40 hetero A substituted or unsubstituted C 1 to C 60 alkyl group, a substituted or unsubstituted C 6 to C 60 aryl group, a substituted or unsubstituted heteroaryl group having 5 to 60 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkyloxy group, An unsubstituted C 6 to C 60 aryloxy group, a substituted or unsubstituted C 3 to C 40 alkylsilyl group, a substituted or unsubstituted C 6 to C 60 arylsilyl group, a substituted or unsubstituted C 2 ~ C 40 alkyl boron group, an aryl phosphonic a substituted or unsubstituted C 6 ~ C 60 aryl boron group, a substituted or unsubstituted C 6 ~ C 60 of pingi, A substituted or unsubstituted C 6 to C 60 arylphosphine oxide group, and a substituted or unsubstituted C 6 to C 60 arylamine group.

이때 넓은 밴드갭과 열안정성을 고려했을 때, 상기 Ar1 은 치환 또는 비치환된 C6~C60의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 60의 헤테로아릴기가 바람직하다. 또한 상기 Ar2 내지 Ar8은 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C6~C60의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 60의 헤테로아릴기가 바람직하다. In this case, considering the wide band gap and thermal stability, Ar 1 is preferably a substituted or unsubstituted C 6 to C 60 aryl group, or a substituted or unsubstituted heteroaryl group having 5 to 60 nucleus atoms. Ar 2 to Ar 8 each represent a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 6 to C 60 aryl group, a substituted or unsubstituted heteroaryl group having 5 to 60 nuclear atoms desirable.

본 발명의 화학식 1로 표기되는 화합물에서, X는 N(Ar2)이고, Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6~C40의 아릴기, 및 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군으로부터 선택되는 것이 바람직하다. 여기서, 상기 C6~C40의 아릴기, 핵원자수 5~40의 헤테로아릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C6~C40의 아릴실릴기, C2~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기, 및 C6~C60의 아릴아민기로 이루어진 군으로부터 선택되는 하나 이상의 치환기로 치환되거나 또는 비치환될 수 있으며, 이때 복수 개의 치환기가 도입되는 경우 이들 치환기는 서로 동일하거나 또는 상이할 수 있다. In the compounds represented by formula (1) of the present invention, X is N (Ar 2 ), Ar 1 and Ar 2 are each independently a substituted or unsubstituted C 6 to C 40 aryl group, and a substituted or unsubstituted nucleus And a heteroaryl group having 5 to 40 atoms. The C 6 -C 40 aryl group and the heteroaryl group having 5 to 40 nuclear atoms are each independently selected from the group consisting of deuterium, halogen, cyano, nitro, C 1 -C 40 alkyl, C 2 -C 40 alk A C 2 to C 40 alkynyl group, a C 6 to C 40 aryl group, a heteroaryl group having 5 to 40 nuclear atoms, a C 6 to C 40 aryloxy group, a C 1 to C 40 alkyloxy group , A C 6 to C 40 arylamine group, a C 3 to C 40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C 1 to C 40 alkylsilyl group, a C 6 to C 40 arylsilyl group , C of 2 ~ C 40 group of an alkyl boron, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 of the An arylamine group, and the like. When a plurality of substituents are introduced, these substituents may be the same as or different from each other.

본 발명에 따른 화학식 1의 화합물의 치환체인, R1 내지 R12, Ar1 내지 Ar8는 각각 독립적으로 수소, 또는 하기 치환체(작용기) 그룹, 일례로 S1 ~ S192로부터 선택되는 것이 바람직하며, 특히 R1 내지 R12, Ar1 및 Ar2은 수소 또는 하기 치환체 군(S1 ~ S192)으로부터 선택되는 것이 더욱 바람직하다. 그러나 이에 한정되지는 않는다. 다만, 상기 정의된 R1 내지 R12에서, 화학식 2와 축합고리를 형성하는 치환기, 일례로 R6와 R7 및/또는 R7와 R8는 제외된다. R 1 to R 12 and Ar 1 to Ar 8, which are substituents of the compound of formula (1) according to the present invention, are each independently selected from hydrogen or the following substituent (functional group), for example, from S1 to S192, More preferably, R 1 to R 12 , Ar 1 and Ar 2 are selected from hydrogen or the following substituent group (S1 to S192). However, it is not limited thereto. However, in the above-defined R 1 to R 12 , the substituent forming the condensation ring with the formula (2), for example, R 6 and R 7 and / or R 7 and R 8 are excluded.

Figure 112012086902721-pat00003
Figure 112012086902721-pat00003

Figure 112012086902721-pat00004

Figure 112012086902721-pat00004

Figure 112012086902721-pat00005
Figure 112012086902721-pat00005

본 발명의 화학식 1로 표시되는 화합물은 하기 화학식 3 내지 화학식 6 중 어느 하나의 화학식으로 표시되는 화합물로 보다 구체화될 수 있다. The compound represented by the formula (1) of the present invention may be further represented by a compound represented by the following formula (3) to (6).

Figure 112012086902721-pat00006
Figure 112012086902721-pat00006

Figure 112012086902721-pat00007
Figure 112012086902721-pat00007

Figure 112012086902721-pat00008
Figure 112012086902721-pat00008

Figure 112012086902721-pat00009
Figure 112012086902721-pat00009

상기 화학식 3 내지 화학식 6 에서,In the above Chemical Formulas 3 to 6,

X, R1 내지 R12, Ar1 내지 Ar8은 각각 화학식 1에서 정의된 바와 동일하다.X, R 1 to R 12 , and Ar 1 to Ar 8 are each the same as defined in formula (1).

상기 화학식 3 내지 화학식 6으로 표시되는 화합물의 구체적인 예로는 하기 화학식으로 표시되는 화합물 군이 있다.Specific examples of the compounds represented by the formulas (3) to (6) include compounds represented by the following formulas.

Figure 112012086902721-pat00010
Figure 112012086902721-pat00010

상기 예시된 화학식에서, Ar1~Ar8, R1~R12는 각각 화학식 1에서 정의된 바와 동일하다. In the illustrated formulas, Ar 1 to Ar 8 and R 1 to R 12 are each the same as defined in formula (1).

전술한 화학식에서, X가 N(Ar2)인 경우, Ar1 및 Ar2는 서로 같거나 상이하며, 각각 독립적으로 치환 또는 비치환된 C6~C40의 아릴기, 및 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군으로부터 선택되고, In the above formula, when X is N (Ar 2 ), Ar 1 and Ar 2 are the same or different and each independently represents a substituted or unsubstituted C 6 -C 40 aryl group, and a substituted or unsubstituted A heteroaryl group having 5 to 40 nuclear atoms,

R1 내지 R12는 서로 같거나 동일하며, 각각 독립적으로 수소 또는 S1 ~ S192로 구성된 치환체 군으로부터 선택되는 것이 바람직하며, 수소 또는 하기 예시되는 치환체 군에서 선택되는 것이 더욱 바람직하다.R 1 to R 12 are the same as or different from each other, and are each independently selected from the group consisting of hydrogen or a substituent group composed of S 1 to S 192, more preferably selected from the group consisting of hydrogen and the substituents exemplified below.

또한 X가 C(Ar3)(Ar4), Si(Ar5)(Ar6), P(Ar7), B(Ar8)인 경우, Ar3 내지 Ar8는 서로 같거나 동일하며, 각각 독립적으로 C1~C40의 알킬기, 치환 또는 비치환된 C6~C60의 아릴기로 이루어진 군에서 선택되는 것이 바람직하고, 특히 메틸기 또는 페닐기일 때 더욱 바람직하다. 여기서, R1 내지 R12는 서로 같거나 동일하며, 각각 독립적으로 수소 또는 S1 ~ S192로 구성된 치환체 군으로부터 선택되는 것이 바람직하며, 수소 또는 하기 예시되는 치환체 군에서 선택되는 것이 더욱 바람직하다.When X is C (Ar 3 ) (Ar 4 ), Si (Ar 5 ) (Ar 6 ), P (Ar 7 ) or B (Ar 8 ), Ar 3 to Ar 8 are the same or the same It is preferably independently selected from the group consisting of a C 1 to C 40 alkyl group and a substituted or unsubstituted C 6 to C 60 aryl group, more preferably a methyl group or a phenyl group. Here, R 1 to R 12 are the same as or different from each other, and are each independently selected from the group consisting of hydrogen or a substituent group composed of S 1 to S 192, and more preferably hydrogen or a substituent group exemplified below.

Figure 112012086902721-pat00011
Figure 112012086902721-pat00011

본 발명에서 사용된 "비치환된 알킬"은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등을 포함한다. As used herein, "unsubstituted alkyl" is a monovalent substituent derived from a straight or branched saturated hydrocarbon having 1 to 40 carbon atoms, and examples thereof include methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso -Amyl, hexyl, and the like.

"비치환된 알케닐(alkenyl)"은 탄소-탄소 이중 결합을 1개 이상 가진, 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등이 있으며, 이에 한정되는 것은 아니다. "Unsubstituted alkenyl" is a monovalent substituent derived from a straight or branched unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon double bond. Examples thereof include vinyl, allyl, but are not limited to, allyl, isopropenyl, 2-butenyl, and the like.

"비치환된 알키닐(alkynyl)"은 탄소-탄소 삼중 결합을 1개 이상 가진, 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 에타인일(ethynyl), 2-프로파인일(2-propynyl) 등이 있는데, 이에 제한되는 것은 아니다."Unsubstituted alkynyl" is a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon triple bond. Examples thereof include ethynyl, , 2-propynyl, and the like, but are not limited thereto.

"비치환된 아릴"은 단독 고리 또는 2 이상의 고리가 조합된, 탄소수 6 내지 60의 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태로 부착될 수 있다. 아릴의 예로는 페닐, 나프틸, 페난트릴, 안트릴 등이 포함되며 이에 한정되는 것은 아니다."Unsubstituted aryl" means a monovalent substituent derived from an aromatic hydrocarbon having 6 to 60 carbon atoms, either alone or in combination with at least two rings. Two or more rings may be attached to each other in a pendant or condensed form. Examples of aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.

"비치환된 헤테로아릴"은 핵원자수 5 내지 40의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로원자로 치환된다. 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태로 부착될 수 있고, 나아가 아릴기와의 축합된 형태도 포함하는 것으로 해석된다. 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리; 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리를 포함하고, 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등도 포함하는 것으로 해석한다."Unsubstituted heteroaryl" means a monovalent substituent derived from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 40 nuclear atoms. One or more carbons, preferably one to three carbons, of the ring are substituted with a heteroatom such as N, O, S or Se. Two or more rings may be attached in a pendant or condensed form to each other and further include a condensed form with an aryl group. Examples of heteroaryl include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, and triazinyl; Such as phenoxathienyl, indolizinyl, indolyl, purinyl, quinolyl, benzothiazole, carbazolyl, and the like. Includes rings and is also meant to include 2-furanyl, N-imidazolyl, 2-isoxazolyl, 2-pyridinyl, 2-pyrimidinyl and the like.

"비치환된 아릴옥시"는 RO-로 표시되는 1가의 치환기로서, 상기 R은 탄소수 5 내지 60의 아릴이다. 아릴옥시의 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등이 있다."Unsubstituted aryloxy" is a monovalent substituent represented by RO-, wherein R is aryl having 5 to 60 carbon atoms. Examples of aryloxy include phenyloxy, naphthyloxy, diphenyloxy, and the like.

"비치환된 알킬옥시"는 R′O-로 표시되는 1가의 치환기로서, 상기 R′는 1 내지 40개의 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함하는 것으로 해석한다. 알킬옥시의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등이 포함될 수 있으며 이에 한정되지는 않는다. "Unsubstituted alkyloxy" means a monovalent substituent group represented by R'O-, wherein R 'represents an alkyl having 1 to 40 carbon atoms, and may have a linear, branched or cyclic structure . Examples of alkyloxy include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.

"비치환된 아릴아민"은 탄소수 6 내지 60의 아릴로 치환된 아민을 의미한다."Unsubstituted arylamine" means an amine substituted with aryl having 6 to 60 carbon atoms.

"비치환된 시클로알킬"은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이러한 사이클로알킬의 예로는 사이클로프로필, 사이클로펜틸, 사이클로헥실, 놀보닐(norbornyl), 아다만틴(adamantine) 등이 포함되지만 이에 한정되는 것은 아니다. "Unsubstituted cycloalkyl" means a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having from 3 to 40 carbon atoms. Examples of such cycloalkyls include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.

"비치환된 헤테로시클로알킬"은 핵원자수 3 내지 40의 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O 또는 S와 같은 헤테로 원자로 치환된다. 이의 비제한적인 예로는 모르폴린, 피페라진 등이 있다."Unsubstituted heterocycloalkyl" means a monovalent substituent derived from a non-aromatic hydrocarbon having 3 to 40 nuclear atoms, wherein at least one of the carbons, preferably one to three carbons, is replaced by N, O, or S Lt; / RTI &gt; Non-limiting examples thereof include morpholine, piperazine, and the like.

"알킬실릴"은 탄소수 1 내지 40의 알킬로 치환된 실릴이고, "아릴실릴"은 탄소수 5 내지 40의 아릴로 치환된 실릴을 의미한다."Alkylsilyl" is silyl substituted with alkyl having 1 to 40 carbon atoms, and "arylsilyl" means silyl substituted with aryl having 5 to 40 carbon atoms.

"축합 고리"는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다."Condensation ring" means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.

본 발명의 화학식 1의 화합물은 일반적인 합성방법에 따라 합성될 수 있다(Chem . Rev ., 60:313 (1960); J. Chem . SOC. 4482 (1955); Chem. Rev. 95: 2457 (1995) 등 참조). 본 발명의 화합물에 대한 상세한 합성 과정은 후술하는 합성예에서 구체적으로 기술하도록 한다.
The compounds of general formula (I) of the present invention can be synthesized according to the general synthetic method (Chem Rev, 60: 313 ( 1960); J. Chem SOC 4482 (1955); Chem Rev. 95:..... 2457 (1995 ). Detailed synthesis of the compound of the present invention will be described in detail in Synthesis Examples to be described later.

<유기 전계 발광 소자>&Lt; Organic electroluminescent device &

한편, 본 발명의 다른 측면은 상기한 본 발명에 따른 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자에 관한 것이다. According to another aspect of the present invention, there is provided an organic electroluminescent device comprising the compound represented by Formula 1 according to the present invention.

구체적으로, 본 발명에 따른 유기 전계 발광 소자는 양극(anode), 음극(cathode), 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물, 바람직하게는 화학식 3로 표시되는 화합물 내지 화학식 6으로 표시되는 화합물 중 어느 하나 이상을 포함한다. 이때, 상기 화학식 3 내지 화학식 6으로 표시되는 화합물은 단독으로 또는 2 이상이 혼합되어 사용될 수 있다.Specifically, the organic electroluminescent device according to the present invention includes at least one anode, an anode, and at least one organic layer sandwiched between the anode and the cathode, wherein at least one of the one or more organic layers Includes any one or more of the compounds represented by the above-mentioned general formula (1), preferably the compounds represented by the general formulas (3) to (6). At this time, the compounds represented by the formulas (3) to (6) may be used singly or in combination of two or more.

여기서, 상기 1층 이상의 유기물층은 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 중 어느 하나 이상일 수 있고, 바람직하게는 정공 주입/수송층, 발광층 또는 전자수송층일 수 있고, 보다 바람직하게는 발광층일 수 있다.Here, the one or more organic layers may be at least one of a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and an electron injecting layer, and may preferably be a hole injecting / transporting layer, a light emitting layer or an electron transporting layer, Emitting layer.

본 발명의 일례에 따르면, 유기 전계 발광 소자의 발광층은 호스트 재료를 포함할 수 있는데, 이때 호스트 재료로서 상기 화학식 1의 화합물을 포함할 수 있다. 이와 같이, 상기 화학식 1의 화합물을 유기 전계 발광 소자의 발광층 재료, 바람직하게는 청색, 녹색, 적색의 인광 호스트로 포함할 경우, 발광층에서 정공과 전자의 결합력이 높아지기 때문에, 유기 전계 발광 소자의 효율(발광효율 및 전력효율), 수명, 휘도 및 구동전압 등이 향상될 수 있다. 상기 화학식 1로 표시되는 화합물은 청색, 녹색 및/또는 적색의 인광 호스트, 형광 호스트, 또는 도펀트 재료로서 유기 발광 소자에 포함될 수 있다. According to an embodiment of the present invention, the light emitting layer of the organic electroluminescent device may include a host material, and the host material may include the compound of the above formula (1). Thus, when the compound of Formula 1 is incorporated into a light emitting layer material of an organic electroluminescent device, preferably a blue, green, or red phosphorescent host, the bonding strength between holes and electrons in the light emitting layer is increased. (Luminous efficiency and power efficiency), lifetime, luminance, driving voltage, and the like can be improved. The compound represented by Formula 1 may be included in an organic light emitting device as a blue, green, and / or red phosphorescent host, a fluorescent host, or a dopant material.

전술한 본 발명에 따른 유기 전계 발광 소자의 구조는 특별히 한정되지 않으며, 예컨대 기판, 양극, 정공주입층, 정공수송층, 발광층, 전자수송층 및 음극이 순차적으로 적층된 구조일 수 있다. 이때, 상기 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 중 하나 이상은 상기 화학식 1로 표시되는 화합물을 포함할 수 있고, 바람직하게는 발광층이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 이때, 본 발명의 화합물은 발광층의 인광 호스트로 이용될 수 있다. 상기 전자수송층 위에는 전자주입층이 추가로 적층될 수 있다. The structure of the organic electroluminescent device according to the present invention is not particularly limited and may be a structure in which a substrate, an anode, a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and a cathode are sequentially stacked. At least one of the hole injecting layer, the hole transporting layer, the light emitting layer, the electron transporting layer, and the electron injecting layer may include a compound represented by Formula 1, and preferably, the emitting layer includes a compound represented by Formula 1 . At this time, the compound of the present invention can be used as a phosphorescent host of the light emitting layer. An electron injection layer may be further stacked on the electron transport layer.

또한, 본 발명에 따른 유기 전계 발광 소자의 구조는 양극, 1층 이상의 유기물층 및 음극이 순차적으로 적층될 뿐만 아니라, 전극과 유기물층 계면에 절연층 또는 접착층이 삽입된 구조일 수 있다.In addition, the structure of the organic electroluminescent device according to the present invention may be a structure in which an anode, one or more organic layers and an anode are sequentially laminated, and an insulating layer or an adhesive layer is inserted into the interface between the electrode and the organic layer.

본 발명에 따른 유기 전계 발광 소자는 상기 1층 이상의 유기물층 (예컨대, 발광층, 정공수송층 및/또는 전자수송층)이 상기 화학식 1로 표시되는 화합물을 포함하도록 형성하는 것을 제외하고는, 당 기술 분야에 알려져 있는 재료 및 방법을 이용하여 다른 유기물층 및 전극을 형성하여 제조될 수 있다.The organic electroluminescent device according to the present invention is known in the art except that the one or more organic layers (for example, a light emitting layer, a hole transporting layer and / or an electron transporting layer) include a compound represented by Formula 1 Can be produced by forming other organic material layers and electrodes using the materials and methods.

상기 유기물층은 진공 증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이들에만 한정되지 않는다.The organic material layer may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.

본 발명에서 사용 가능한 기판으로는 특별히 한정되지 않으며, 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름 및 시트 등이 사용될 수 있다.The substrate usable in the present invention is not particularly limited, and a silicon wafer, quartz, a glass plate, a metal plate, a plastic film and a sheet can be used.

사용 가능한 양극 물질의 비제한적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 또는 폴리아닐린과 같은 전도성 고분자; 및 카본블랙 등이 있는데, 이에 한정되지 않는다.Non-limiting examples of usable cathode materials include metals such as vanadium, chromium, copper, zinc, gold, or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole or polyaniline; And carbon black, but are not limited thereto.

사용 가능한 음극 물질의 비제한적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; 및 LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있는데, 이에 한정되지 않는다.Non-limiting examples of usable cathode materials include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin or lead or alloys thereof; And multi-layer structure materials such as LiF / Al or LiO 2 / Al, but are not limited thereto.

또한, 정공 주입층, 정공 수송층, 전자 주입층 및 전자 수송층은 특별히 한정되는 것은 아니며, 당 업계에 알려진 통상의 물질이 사용될 수 있다.The hole injecting layer, the hole transporting layer, the electron injecting layer and the electron transporting layer are not particularly limited, and conventional materials known in the art can be used.

이하 본 발명을 준비예 및 합성예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 준비예 및 합성예는 본 발명을 예시하는 것일 뿐 본 발명이 하기 준비예 및 합성예에 의해 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to Preparation Examples and Synthesis Examples. However, the following Preparative Examples and Synthesis Examples are merely illustrative of the present invention, and the present invention is not limited by the following Preparation Examples and Synthesis Examples.

[준비예 1] IC-1과 IC-2의 합성[Preparation Example 1] Synthesis of IC-1 and IC-2

<단계 1> 4-bromo-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole의 합성<Step 1> Synthesis of 4-bromo-6-phenyl-2,6-dihydro-1H-benzo [def] carbazole

Figure 112012086902721-pat00012
Figure 112012086902721-pat00012

질소 기류 하에서 4-bromo-2,6-dihydro-1H-benzo[def]carbazole (3.38 g, 12.40 mmol), 1-bromobenzene (2.14 g, 37.18 mmol), Cu powder(0.15 g, 2.48 mmol), K2CO3(3.42 g, 24.79 mmol), Na2SO4(3.53 g, 24.79 mmol) 및 nitrobenzene(100 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. (3.38 g, 12.40 mmol), 1-bromobenzene (2.14 g, 37.18 mmol), Cu powder (0.15 g, 2.48 mmol), K 2 CO 3 (3.42 g, 24.79 mmol), Na 2 SO 4 (3.53 g, 24.79 mmol) and nitrobenzene (100 ml) were mixed and stirred at 190 ° C for 12 hours.

반응이 종결된 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리한 다음 MgSO4를 사용하여 물을 제거하였다. 유기층의 용매를 제거한 후 컬럼크로마토그래피로 정제하여 목적 화합물인 4-bromo-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole (3.06 g, 8.80 mmol, 수율 71%)을 얻었다.After the reaction was completed, the nitrobenzene was removed, the organic layer was separated with methylene chloride, and water was removed using MgSO 4 . The solvent of the organic layer was removed, and the residue was purified by column chromatography to obtain the target compound, 4-bromo-6-phenyl-2,6-dihydro-1H-benzo [def] carbazole (3.06 g, 8.80 mmol, yield 71%).

1H-NMR : δ 2.83 (m, 4H), 7.03 (m, 2H), 7.31 (m, 2H), 7.53 (m, 4H), 7.76 (d, 1H)
1 H-NMR: δ 2.83 ( m, 4H), 7.03 (m, 2H), 7.31 (m, 2H), 7.53 (m, 4H), 7.76 (d, 1H)

<단계 2> 4-(2-nitrophenyl)-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole의 합성<Step 2> Synthesis of 4- (2-nitrophenyl) -6-phenyl-2,6-dihydro-1H-benzo [

Figure 112012086902721-pat00013
Figure 112012086902721-pat00013

질소 기류 하에서 3.06 g (8.80 mmol)의 4-bromo-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole, 1.61 g (9.67 mmol)의 2-nitrophenylboronic acid, 1.06 g (26.37 mmol)의 NaOH과 100 ml/50 ml의 THF/H2O를 넣고 교반하였다. 40℃에서 0.51 g (5 mol%)의 Pd(PPh3)4를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터링하였다. 필터링된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 4-(2-nitrophenyl)-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole (2.82 g, 7.22 mmol, 수율 82 %)을 획득하였다. 2-nitrophenylboronic acid, 1.06 g (26.37 mmol) of 4-bromo-6-phenyl-2,6-dihydro-1H- Of NaOH and 100 ml / 50 ml of THF / H 2 O were added and stirred. 0.51 g (5 mol%) of Pd (PPh 3 ) 4 was added at 40 ° C, and the mixture was stirred at 80 ° C for 12 hours. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was filtered with MgSO 4 . After removing the solvent of the filtered organic layer, the desired compound, 4- (2-nitrophenyl) -6-phenyl-2,6-dihydro-1H-benzo [def] carbazole (2.82 g, 7.22 mmol, yield 82%).

1H-NMR : δ 2.84 (m, 4H), 7.01 (d, 1H), 7.33 (t, 1H), 7.59 (m, 7H), 7.99 (m, 3H)
1 H-NMR: δ 2.84 ( m, 4H), 7.01 (d, 1H), 7.33 (t, 1H), 7.59 (m, 7H), 7.99 (m, 3H)

<단계 3> IC-1과 IC-2의 합성<Step 3> Synthesis of IC-1 and IC-2

Figure 112012086902721-pat00014
Figure 112012086902721-pat00014

질소 기류 하에서 4-(2-nitrophenyl)-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole 2.82 g (7.22 mmol)과 triphenylphosphine 4.73 g (18.05 mmol), 1,2-dichlorobenzene 30 ml를 넣은 후 12시간 교반하였다. 반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하였다. 추출된 유기층은 MgSO4로 물을 제거하고, 컬럼크로마토그래피를 이용하여 목적 화합물인 IC-1 (0.99 g, 2.75 mmol, 수율 38 %) 과 IC-2 (0.97 g, 2.74 mmol, 수율 37 %)을 각각 획득하였다. A mixture of 2.82 g (7.22 mmol) of 4- (2-nitrophenyl) -6-phenyl-2,6-dihydro-1H-benzo [def] carbazole, 4.73 g (18.05 mmol) of triphenylphosphine and 30 ml of 1,2-dichlorobenzene And the mixture was stirred for 12 hours. After completion of the reaction, 1,2-dichlorobenzene was removed and extracted with dichloromethane. The extracted organic layer was washed with MgSO 4 and purified by column chromatography to obtain IC-1 (0.99 g, 2.75 mmol, yield 38%) and IC-2 (0.97 g, 2.74 mmol, yield 37% Respectively.

IC-1 의 1H-NMR : δ 2.83 (m, 4H), 7.00 (d, 1H), 7.30 (m, 2H), 7.54 (m, 8H), 7.76 (d, 1H), 8.12 (d, 1H), 10.01 (s, 1H) IC-1 1 H-NMR of: δ 2.83 (m, 4H) , 7.00 (d, 1H), 7.30 (m, 2H), 7.54 (m, 8H), 7.76 (d, 1H), 8.12 (d, 1H ), 10.01 (s, 1 H)

IC-2 의 1H-NMR : δ 2.84 (m, 4H), 7.00 (d, 1H), 7.28 (m, 3H), 7.56 (m, 7H), 7.77 (d, 1H), 8.12 (d, 1H), 10.21 (s, 1H)
1 of IC-2 H-NMR: δ 2.84 (m, 4H), 7.00 (d, 1H), 7.28 (m, 3H), 7.56 (m, 7H), 7.77 (d, 1H), 8.12 (d, 1H ), 10.21 (s, 1 H)

[준비예 2] IC-3과 IC-4의 합성[Preparation Example 2] Synthesis of IC-3 and IC-4

<단계 1> 6-(biphenyl-4-yl)-4-bromo-2,6-dihydro-1H-benzo[def]carbazole의 합성Synthesis of 6- (biphenyl-4-yl) -4-bromo-2,6-dihydro-1H-benzo [def] carbazole

Figure 112012086902721-pat00015
Figure 112012086902721-pat00015

1-bromobenzene 대신 4-bromobiphenyl (8.67 g, 37.18 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 6-(biphenyl-4-yl)-4-bromo-2,6-dihydro-1H-benzo[def]carbazole을 얻었다.(Biphenyl-4-yl) -4-bromo (4-bromo-4-methoxyphenyl) propanoate was obtained by following the same procedure as <Step 1> of Preparation Example 1 except that 4-bromobiphenyl (8.67 g, 37.18 mmol) -2,6-dihydro-1H-benzo [def] carbazole.

1H-NMR : δ 2.84 (m, 4H), 7.01 (m, 2H), 7.31 (m, 2H), 7.64 (m, 7H), 7.79 (m, 3H)
1 H-NMR: δ 2.84 ( m, 4H), 7.01 (m, 2H), 7.31 (m, 2H), 7.64 (m, 7H), 7.79 (m, 3H)

<단계 2> 6-(biphenyl-4-yl)-4-(2-nitrophenyl)-2,6-dihydro-1H-benzo[def]carbazole 의 합성Synthesis of 6- (biphenyl-4-yl) -4- (2-nitrophenyl) -2,6-dihydro-1H-benzo [def] carbazole

Figure 112012086902721-pat00016
Figure 112012086902721-pat00016

4-bromo-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole 대신 6-(biphenyl-4-yl)-4-bromo-2,6-dihydro-1H-benzo[def]carbazole (3.72 g, 8.80 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 2>와 동일한 과정을 수행하여 6-(biphenyl-4-yl)-4-(2-nitrophenyl)-2,6-dihydro-1H-benzo[def]carbazole을 얻었다.(Biphenyl-4-yl) -4-bromo-2,6-dihydro-1H-benzo [f] carbazole instead of 4-bromo-6-phenyl-2,6- dihydro- 4-yl) -4- (2-nitrophenyl) -2,6-dihydroxybenzoic acid was prepared by following the procedure of Step 2 of Preparation Example 1, -dihydro-1H-benzo [def] carbazole.

1H-NMR : δ 2.85 (m, 4H), 7.01 (d, 1H), 7.28 (t, 1H), 7.51 (m, 6H), 7.69 (m, 7H), 7.98 (m, 3H)
1 H-NMR: δ 2.85 ( m, 4H), 7.01 (d, 1H), 7.28 (t, 1H), 7.51 (m, 6H), 7.69 (m, 7H), 7.98 (m, 3H)

<단계 3> IC-3과 IC-4의 합성<Step 3> Synthesis of IC-3 and IC-4

Figure 112012086902721-pat00017
Figure 112012086902721-pat00017

4-(2-nitrophenyl)-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole 대신 6-(biphenyl-4-yl)-4-(2-nitrophenyl)-2,6-dihydro-1H-benzo[def]carbazole (3.27 g, 7.22 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 목적 화합물 IC-3과 IC-4를 각각 얻었다.6- (biphenyl-4-yl) -4- (2-nitrophenyl) -2,6-dihydro-1H-benzo [ The procedure of Step 3 of Preparation Example 1 was repeated to obtain the desired compounds IC-3 and IC-4, respectively, except that 1H-benzo [def] carbazole (3.27 g, 7.22 mmol) was used.

IC-3 의 1H-NMR : δ 2.83 (m, 4H), 6.91 (d, 1H), 7.28 (m, 2H), 7.49 (m, 7H), 7.66 (m, 6H), 8.11 (d, 1H), 10.07 (s, 1H)IC-3 1 H-NMR of: δ 2.83 (m, 4H) , 6.91 (d, 1H), 7.28 (m, 2H), 7.49 (m, 7H), 7.66 (m, 6H), 8.11 (d, 1H ), 10.07 (s, 1 H)

IC-4 의 1H-NMR : δ 2.83 (m, 4H), 6.90 (d, 1H), 7.29 (m, 3H), 7.52 (m, 6H), 7.67 (m, 6H), 8.11 (d, 1H), 10.22 (s, 1H)
IC-4 1 H-NMR of: δ 2.83 (m, 4H) , 6.90 (d, 1H), 7.29 (m, 3H), 7.52 (m, 6H), 7.67 (m, 6H), 8.11 (d, 1H ), 10.22 (s, 1 H)

[준비예 3] IC-5과 IC-6의 합성[Preparation Example 3] Synthesis of IC-5 and IC-6

<단계 1> 6-(biphenyl-3-yl)-4-bromo-2,6-dihydro-1H-benzo[def]carbazole의 합성Synthesis of 6- (biphenyl-3-yl) -4-bromo-2,6-dihydro-1H-benzo [def] carbazole

Figure 112012086902721-pat00018
Figure 112012086902721-pat00018

1-bromobenzene 대신 3-bromobiphenyl (8.67 g, 37.18 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 6-(biphenyl-3-yl)-4-bromo-2,6-dihydro-1H-benzo[def]carbazole을 얻었다.(Biphenyl-3-yl) -4-bromo (4-bromo-2-methylpyridin-2-ylamine) was obtained by following the same procedure as in <Step 1> of Preparation Example 1 except that 3-bromobiphenyl (8.67 g, 37.18 mmol) -2,6-dihydro-1H-benzo [def] carbazole.

1H-NMR : δ 2.84 (m, 4H), 6.97 (m, 2H), 7.28 (m, 2H), 7.48 (m, 8H), 7.76 (d, 1H), 8.01 (s, 1H)
1 H-NMR: δ 2.84 ( m, 4H), 6.97 (m, 2H), 7.28 (m, 2H), 7.48 (m, 8H), 7.76 (d, 1H), 8.01 (s, 1H)

<단계 2> 6-(biphenyl-3-yl)-4-(2-nitrophenyl)-2,6-dihydro-1H-benzo[def]carbazole 의 합성Synthesis of 6- (biphenyl-3-yl) -4- (2-nitrophenyl) -2,6-dihydro-1H-benzo [def] carbazole

Figure 112012086902721-pat00019
Figure 112012086902721-pat00019

4-bromo-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole 대신 6-(biphenyl-3-yl)-4-bromo-2,6-dihydro-1H-benzo[def]carbazole(3.73 g, 8.8 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 2>와 동일한 과정을 수행하여 6-(biphenyl-3-yl)-4-(2-nitrophenyl)-2,6-dihydro-1H-benzo[def]carbazole을 얻었다.(Biphenyl-3-yl) -4-bromo-2,6-dihydro-1H-benzo [f] carbazole instead of 4-bromo-6-phenyl-2,6- dihydro- 3-yl) -4- (2-nitrophenyl) -2,6-dihydroquinolinecarboxamide was prepared by following the procedure of Step 2 of Preparation Example 1, -dihydro-1H-benzo [def] carbazole.

1H-NMR : δ 2.83 (m, 4H), 6.95 (d, 1H), 7.28 (t, 1H), 7.51 (m, 10H), 7.73 (m, 2H), 8.02 (m, 3H)
1 H-NMR: δ 2.83 ( m, 4H), 6.95 (d, 1H), 7.28 (t, 1H), 7.51 (m, 10H), 7.73 (m, 2H), 8.02 (m, 3H)

<단계 3> IC-5과 IC-6의 합성<Step 3> Synthesis of IC-5 and IC-6

Figure 112012086902721-pat00020
Figure 112012086902721-pat00020

4-(2-nitrophenyl)-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole 대신 6-(biphenyl-3-yl)-4-(2-nitrophenyl)-2,6-dihydro-1H-benzo[def]carbazole (3.3 g, 7.22 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 목적화합물 IC-5과 IC-6를 각각 얻었다.6- (biphenyl-3-yl) -4- (2-nitrophenyl) -2,6-dihydro-1H- benzo [ The procedure of Step 3 of Preparation Example 1 was repeated to obtain the desired compounds IC-5 and IC-6, respectively, except that 1H-benzo [def] carbazole (3.3 g, 7.22 mmol) was used.

IC-5 의 1H-NMR : δ 2.83 (m, 4H), 6.87 (d, 1H), 7.28 (m, 2H), 7.50 (m, 11H), 7.78 (d, 1H), 8.05 (m, 2H), 10.01 (s, 1H)The IC-5 1 H-NMR: δ 2.83 (m, 4H), 6.87 (d, 1H), 7.28 (m, 2H), 7.50 (m, 11H), 7.78 (d, 1H), 8.05 (m, 2H ), 10.01 (s, 1 H)

IC-6 의 1H-NMR : δ 2.83 (m, 4H), 6.87 (d, 1H), 7.27 (m, 3H), 7.51 (m, 10H), 7.78 (d, 1H), 8.04 (m, 2H), 10.12 (s, 1H)
IC-6 1 H-NMR of: δ 2.83 (m, 4H) , 6.87 (d, 1H), 7.27 (m, 3H), 7.51 (m, 10H), 7.78 (d, 1H), 8.04 (m, 2H ), 10.12 (s, 1 H)

[준비예 4] IC-7의 합성[Preparation Example 4] Synthesis of IC-7

<단계 1> tert-butyl 4-bromo-1H-benzo[def]carbazole-6(2H)-carboxylate의 합성Synthesis of tert-butyl 4-bromo-1H-benzo [def] carbazole-6 (2H) -carboxylate

Figure 112012086902721-pat00021
Figure 112012086902721-pat00021

4-bromo-2,6-dihydro-1H-benzo[def]carbazole (16.33 g, 60.0 mmol), Di-tert-butyldicarbonate (26.0 ml, 113.2 mmol), 4-Dimethylaminopyridine (7.35 g, 60.1 mmol)을 Acetonitrile 300 ml에 녹이고, 상온에서 2시간 교반하였다. 반응이 종료 된 후에 물을 붓고, 메틸렌클로라이드로 유기층을 분리한 다음 MgSO4를 사용하여 물을 제거하였다. 유기층의 용매를 제거한 후 컬럼크로마토그래피로 정제하여 목적 화합물인 tert-butyl 4-bromo-1H-benzo[def]carbazole-6(2H)-carboxylate (20.55 g, 55.2 mmol, 수율 92%)을 얻었다.4-Dimethylaminopyridine (7.35 g, 60.1 mmol) was added to a solution of 4-bromo-2,6-dihydro-1H-benzo [ 300 ml, and the mixture was stirred at room temperature for 2 hours. After the reaction was completed, water was poured, the organic layer was separated with methylene chloride, and then water was removed using MgSO 4 . Tert-butyl 4-bromo-1H-benzo [def] carbazole-6 (2H) -carboxylate (20.55 g, 55.2 mmol, yield 92%) was obtained by purifying the target compound by removing the solvent of the organic layer.

1H-NMR : δ 1.59 (s, 9H), 2.85 (m, 4H), 7.03 (d, 1H), 7.27 (m, 3H), 7.51 (d, 1H)
1 H-NMR: δ 1.59 ( s, 9H), 2.85 (m, 4H), 7.03 (d, 1H), 7.27 (m, 3H), 7.51 (d, 1H)

<단계 2> tert-butyl 4-(2-nitrophenyl)-1H-benzo[def]carbazole-6(2H)-carboxylate의 합성<Step 2> Synthesis of tert-butyl 4- (2-nitrophenyl) -1H-benzo [def] carbazole-6 (2H) -carboxylate

Figure 112012086902721-pat00022
Figure 112012086902721-pat00022

4-bromo-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole 대신 tert-butyl 4-(2-nitrophenyl)-1H-benzo[def]carbazole-6(2H)-carboxylate (3.28 g, 8.8 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 2>와 동일한 과정을 수행하여 tert-butyl 4-(2-nitrophenyl)-1H-benzo[def]carbazole-6(2H)-carboxylate을 얻었다.(2-nitrophenyl) -lH-benzo [b] carbazole-6 (2H) -carboxylate (3.28 g, 9.2 mmol) instead of 4-bromo-6-phenyl-2,6- dihydro- (2-nitrophenyl) -lH-benzo [def] carbazole-6 (2H) was obtained in the same manner as Step 2 of Preparation Example 1, -carboxylate.

1H-NMR : δ 1.59 (s, 9H), 2.85 (m, 4H), 7.28 (m, 2H), 7.51 (m, 3H), 7.71 (d, 1H), 7.99 (m, 3H)
1 H-NMR:? 1.59 (s, 9H), 2.85 (m, 4H), 7.28 (m, 2H), 7.51

<단계 3> IC-7-1과 IC-10-1의 합성<Step 3> Synthesis of IC-7-1 and IC-10-1

Figure 112012086902721-pat00023
Figure 112012086902721-pat00023

4-(2-nitrophenyl)-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole 대신 tert-butyl 4-(2-nitrophenyl)-1H-benzo[def]carbazole-6(2H)-carboxylate (2.99 g, 7.22 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 목적화합물 IC-7-1과 IC-10-1을 얻었다.(2-nitrophenyl) -1H-benzo [f] carbazole-6 (2H) - (2-nitrophenyl) -6- carboxylate (2.99 g, 7.22 mmol) was used in place of the compound obtained in Preparation Example 1 to obtain the desired compounds IC-7-1 and IC-10-1.

IC-7-1 의 1H-NMR : δ 1.60 (s, 9H), 2.84 (m, 4H), 7.29 (m, 3H), 7.50 (m, 3H), 7.61 (d, 1H), 8.03 (d, 1H), 10.04 (s, 1H) 1 H-NMR of the IC-7-1: δ 1.60 (s , 9H), 2.84 (m, 4H), 7.29 (m, 3H), 7.50 (m, 3H), 7.61 (d, 1H), 8.03 (d , 1 H), 10.04 (s, 1 H)

IC-10-1 의 1H-NMR : δ 1.60 (s, 9H), 2.83 (m, 4H), 7.27 (m, 3H), 7.51 (m, 3H), 7.61 (d, 1H), 8.04 (d, 1H), 10.13 (s, 1H)
The IC-10-1 1 H-NMR: δ 1.60 (s, 9H), 2.83 (m, 4H), 7.27 (m, 3H), 7.51 (m, 3H), 7.61 (d, 1H), 8.04 (d , &Lt; / RTI &gt; 1H), 10.13 (s, 1H)

<단계 3> IC-7의 합성<Step 3> Synthesis of IC-7

Figure 112012086902721-pat00024
Figure 112012086902721-pat00024

질소 기류 하에서 IC-7-1 (4.74 g, 12.40 mmol), 1-bromobenzene (2.14 g, 37.18 mmol), Cu powder(0.15 g, 2.48 mmol), K2CO3(3.42 g, 24.79 mmol), Na2SO4(3.53 g, 24.79 mmol) 및 nitrobenzene(100 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. (2.14 g, 37.18 mmol), Cu powder (0.15 g, 2.48 mmol), K 2 CO 3 (3.42 g, 24.79 mmol), Na 2 SO 4 (3.53 g, 24.79 mmol) and nitrobenzene (100 ml) were mixed and stirred at 190 ° C for 12 hours.

반응이 종결된 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리한 다음 MgSO4를 사용하여 물을 제거하였다. 유기층의 용매를 제거한 후, 유기화합물을 Silica-gel (500 g)과 함께 Toluene 2000 ml에 넣고 110℃에서 12시간을 교반하였고, filter로 silica-gel을 제거하고 Toluene을 농축하여 목적화합물 IC-7 (2.80 g, 7.81 mmol, 수율 63%)을 얻었다.After the reaction was completed, the nitrobenzene was removed, the organic layer was separated with methylene chloride, and water was removed using MgSO 4 . After removing the solvent of the organic layer, the organic compound was added to 2000 ml of toluene together with 500 g of Silica-gel, stirred at 110 ° C for 12 hours, and silica-gel was removed by filtration. (2.80 g, 7.81 mmol, yield 63%).

1H-NMR : δ 2.84 (m, 4H), 7.33 (m, 4H), 7.52 (m, 6H), 7.91 (d, 1H), 8.04 (d, 1H), 8.55 (d, 1H), 10.03 (s, 1H)
1 H-NMR:? 2.84 (m, 4H), 7.33 (m, 4H), 7.52 (m, 6H), 7.91 (d, s, 1 H)

[준비예 5] IC-8의 합성[Preparation Example 5] Synthesis of IC-8

<단계 1> IC-8의 합성<Step 1> Synthesis of IC-8

Figure 112012086902721-pat00025
Figure 112012086902721-pat00025

1-bromobenzene 대신 4-bromobiphenyl (8.67 g, 37.18 mmol)을 사용하는 것을 제외하고는, 상기 준비예 4의 <단계 3>과 동일한 과정을 수행하여 IC-8을 얻었다.IC-8 was obtained in the same manner as in <Step 3> of Preparation Example 4 except that 4-bromobiphenyl (8.67 g, 37.18 mmol) was used instead of 1-bromobenzene.

1H-NMR : δ 2.85 (m, 4H), 7.35 (m, 4H), 7.48 (m, 6H), 7.69 (m, 4H), 7.96 (m, 2H), 8.53 (d, 1H), 10.04 (s, 1H)
1 H-NMR: δ 2.85 ( m, 4H), 7.35 (m, 4H), 7.48 (m, 6H), 7.69 (m, 4H), 7.96 (m, 2H), 8.53 (d, 1H), 10.04 ( s, 1 H)

[준비예 6] IC-9의 합성[Preparation Example 6] Synthesis of IC-9

<단계 1> IC-9의 합성<Step 1> Synthesis of IC-9

Figure 112012086902721-pat00026
Figure 112012086902721-pat00026

1-bromobenzene 대신 3-bromobiphenyl (8.67 g, 37.18 mmol)을 사용하는 것을 제외하고는, 상기 준비예 4의 <단계 3>과 동일한 과정을 수행하여 IC-9을 얻었다.IC-9 was obtained in the same manner as in <Step 3> of Preparation Example 4 except that 3-bromobiphenyl (8.67 g, 37.18 mmol) was used instead of 1-bromobenzene.

1H-NMR : δ 2.85 (m, 4H), 7.33 (m, 4H), 7.42 (m, 5H), 7.67 (m, 5H), 7.92 (m, 2H), 8.53 (d, 1H), 10.04 (s, 1H)
1 H-NMR: δ 2.85 ( m, 4H), 7.33 (m, 4H), 7.42 (m, 5H), 7.67 (m, 5H), 7.92 (m, 2H), 8.53 (d, 1H), 10.04 ( s, 1 H)

[준비예 7] IC-10의 합성[Preparation Example 7] Synthesis of IC-10

<단계 1> <Step 1> ICIC -10의 합성Synthesis of -10

Figure 112012086902721-pat00027
Figure 112012086902721-pat00027

IC-7-1 대신 IC-10-1 (4.74 g, 12.40 mmol)을 사용하는 것을 제외하고는, 상기 준비예 4의 <단계 3>과 동일한 과정을 수행하여 IC-10을 얻었다.IC-10 was obtained in the same manner as in <Step 3> of Preparation Example 4 except that IC-10-1 (4.74 g, 12.40 mmol) was used instead of IC-7-1.

1H-NMR : δ 2.83 (m, 4H), 7.31 (m, 4H), 7.51 (m, 8H), 7.92 (d, 1H), 10.09 (s, 1H)
1 H-NMR:? 2.83 (m, 4H), 7.31 (m, 4H), 7.51 (m, 8H), 7.92

[준비예 8] IC-11의 합성[Preparation Example 8] Synthesis of IC-11

<단계 1> IC-11의 합성<Step 1> Synthesis of IC-11

Figure 112012086902721-pat00028
Figure 112012086902721-pat00028

IC-7-1 대신 IC-10-1 (4.74 g, 12.40 mmol)을 사용하는 것을 제외하고는, 상기 준비예 5의 <단계 1>과 동일한 과정을 수행하여 IC-11을 얻었다.IC-11 was obtained in the same manner as in <Step 1> of Preparation Example 5 except that IC-10-1 (4.74 g, 12.40 mmol) was used instead of IC-7-1.

1H-NMR : δ 2.84 (m, 4H), 7.32 (m, 4H), 7.51 (m, 7H), 7.76 (m, 5H), 7.99 (d, 1H), 10.08 (s, 1H)
1 H-NMR:? 2.84 (m, 4H), 7.32 (m, 4H), 7.51 (m, 7H)

[준비예 9] IC-12의 합성[Preparation Example 9] Synthesis of IC-12

<단계 1> <Step 1> ICIC -12의 합성Synthesis of -12

Figure 112012086902721-pat00029
Figure 112012086902721-pat00029

IC-7-1 대신 IC-10-1 (4.74 g, 12.40 mmol)을 사용하는 것을 제외하고는, 상기 준비예 6의 <단계 1>과 동일한 과정을 수행하여 IC-12를 얻었다.IC-12 was obtained in the same manner as in <Step 1> of Preparation Example 6 except that IC-10-1 (4.74 g, 12.40 mmol) was used instead of IC-7-1.

1H-NMR : δ 2.84 (m, 4H), 7.35 (m, 4H), 7.54 (m, 6H), 7.79 (m, 6H), 8.01 (d, 1H), 10.11 (s, 1H)
1 H-NMR:? 2.84 (m, 4H), 7.35 (m, 4H), 7.54 (m, 6H), 7.79

[준비예 10] IC-13과 IC-14의 합성[Preparation Example 10] Synthesis of IC-13 and IC-14

<단계 1> 4,8-dibromo-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole의 합성Synthesis of 4,8-dibromo-6-phenyl-2,6-dihydro-1H-benzo [def] carbazole

Figure 112012086902721-pat00030
Figure 112012086902721-pat00030

4-bromo-2,6-dihydro-1H-benzo[def]carbazole 대신 4,8-dibromo-2,6-dihydro-1H-benzo[def]carbazole (4.35 g, 12.40 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 4,8-dibromo-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole을 얻었다.Except that 4,8-dibromo-2,6-dihydro-1H-benzo [def] carbazole (4.35 g, 12.40 mmol) was used instead of 4-bromo-2,6-dihydro-1H- 4-dibromo-6-phenyl-2,6-dihydro-1H-benzo [def] carbazole was obtained in the same manner as in <Step 1> of Preparation Example 1 above.

1H-NMR : δ 2.84 (m, 4H), 7.03 (s, 2H), 7.39 (s, 2H), 7.49 (m, 5H)
1 H-NMR: δ 2.84 ( m, 4H), 7.03 (s, 2H), 7.39 (s, 2H), 7.49 (m, 5H)

<단계 2> 4-bromo-6,8-diphenyl-2,6-dihydro-1H-benzo[def]carbazole의 합성<Step 2> Synthesis of 4-bromo-6,8-diphenyl-2,6-dihydro-1H-benzo [def] carbazole

Figure 112012086902721-pat00031
Figure 112012086902721-pat00031

4-bromo-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole 대신 4,8-dibromo-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole (3.76 g, 8.80 mmol)을 사용하는 것과 2-nitrophenylboronic acid 대신 phenylboronic acid (3.22 g, 26.37 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 2>와 동일한 과정을 수행하여 4-bromo-6,8-diphenyl-2,6-dihydro-1H-benzo[def]carbazole을 얻었다.4-bromo-6-phenyl-2,6-dihydro-1H-benzo [def] carbazole (3.76 g, 8.80 mmol) instead of 4-bromo- Step 2 of Preparation Example 1 was repeated except that phenylboronic acid (3.22 g, 26.37 mmol) was used in place of 2-nitrophenylboronic acid to give 4-bromo-6,8 -diphenyl-2,6-dihydro-1H-benzo [def] carbazole.

1H-NMR : δ 2.84 (m, 4H), 7.08 (m, 2H), 7.39 (m, 4H), 7.53 (m, 8H)
1 H-NMR: δ 2.84 ( m, 4H), 7.08 (m, 2H), 7.39 (m, 4H), 7.53 (m, 8H)

<단계 3> 4-(2-nitrophenyl)-6,8-diphenyl-2,6-dihydro-1H-benzo[def]carbazole 합성 <Step 3> 4- (2-nitrophenyl) -6,8-diphenyl-2,6-dihydro-1H-benzo [def] carbazole Synthesis of

Figure 112012086902721-pat00032
Figure 112012086902721-pat00032

4-bromo-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole 대신 4-bromo-6,8-diphenyl-2,6-dihydro-1H-benzo[def]carbazole (3.73 g, 8.80 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 2>와 동일한 과정을 수행하여 4-(2-nitrophenyl)-6,8-diphenyl-2,6-dihydro-1H-benzo[def]carbazole을 얻었다.4-bromo-6,8-diphenyl-2,6-dihydro-1H-benzo [def] carbazole (3.73 g, 8.80 mmol) instead of 4-bromo-6-phenyl-2,6- dihydro- 2-nitrophenyl) -6,8-diphenyl-2,6-dihydro-1H-benzo [def ] carbazole.

1H-NMR : δ 2.89 (m, 4H), 7.41 (m, 4H), 7.53 (m, 11H), 7.94 (m, 3H)
1 H-NMR:? 2.89 (m, 4H), 7.41 (m, 4H), 7.53

<단계 4> IC-13과 IC-14의 합성<Step 4> Synthesis of IC-13 and IC-14

Figure 112012086902721-pat00033
Figure 112012086902721-pat00033

4-(2-nitrophenyl)-6-phenyl-2,6-dihydro-1H-benzo[def]carbazole 대신 4-(2-nitrophenyl)-6,8-diphenyl-2,6-dihydro-1H-benzo[def]carbazole (3.37 g, 7.22 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 목적화합물 IC-13과 IC-14를 얻었다.Substituting 4- (2-nitrophenyl) -6,8-diphenyl-2,6-dihydro-1H-benzo [b] for 4- (2-nitrophenyl) -6- def] carbazole (3.37 g, 7.22 mmol) was used in place of the compound [IC-13]. IC-13 and IC-14 were obtained in the same manner as in <Step 3> of Preparation Example 1 above.

IC-13 의 1H-NMR : δ 2.87 (m, 4H), 7.42 (m, 6H), 7.54 (m, 10H), 7.94 (s, 1H), 10.04 (s, 1H) 1 H-NMR:? 2.87 (m, 4H), 7.42 (m, 6H), 7.54

IC-14 의 1H-NMR : δ 2.87 (m, 4H), 7.43 (m, 5H), 7.57 (m, 9H), 7.89 (s, 1H), 10.12 (s, 1H)
1 H-NMR:? 2.87 (m, 4H), 7.43 (m, 5H), 7.57 (m, 9H)

[준비예 11] IC-15의 합성[Preparation Example 11] Synthesis of IC-15

<단계 1> tert-butyl 4-(2-(chloromethyl)phenyl)-1H-benzo[def]carbazole-6(2H)-carboxylate의 합성Synthesis of tert-butyl 4- (2- (chloromethyl) phenyl) -lH-benzo [def] carbazole-6 (2H) -carboxylate

Figure 112012086902721-pat00034
Figure 112012086902721-pat00034

2-nitrophenylboronic acid 대신 2-(chloromethyl)phenylboronic acid (1.50 g, 8.80 mmol)을 사용하는 것을 제외하고는, 상기 준비예 4의 <단계 2>와 동일한 과정을 수행하여 tert-butyl 4-(2-(chloromethyl)phenyl)-1H-benzo[def]carbazole-6(2H)-carboxylate을 얻었다.Step 2 of Preparation Example 4 was repeated except that 2- (chloromethyl) phenylboronic acid (1.50 g, 8.80 mmol) was used instead of 2-nitrophenylboronic acid to obtain tert-butyl 4- (2- (chloromethyl) phenyl) -1H-benzo [def] carbazole-6 (2H) -carboxylate.

1H-NMR : δ 1.59 (s, 9H), 2.84 (m, 4H), 4.53 (s, 2H), 7.18 (m, 2H), 7.42 (m, 2H), 7.55 (m, 2H), 7.74 (m, 3H)
1 H-NMR: δ 1.59 ( s, 9H), 2.84 (m, 4H), 4.53 (s, 2H), 7.18 (m, 2H), 7.42 (m, 2H), 7.55 (m, 2H), 7.74 ( m, 3H)

<단계 2> tert-butyl 4,5-dihydrobenzo[def]indeno[2,1-a]carbazole-12(11H)-carboxylate과 tert-butyl 1,2-dihydrobenzo[def]indeno[1,2-b]carbazole-6(12H)-carboxylate의 합성Step 2: Preparation of tert-butyl 4,5-dihydrobenzo [def] indeno [2,1-a] carbazole-12 (11H) ] carbazole-6 (12H) -carboxylate

Figure 112012086902721-pat00035
Figure 112012086902721-pat00035

질소 기류 하에서 tert-butyl 4-(2-(chloromethyl)phenyl)-1H-benzo[def]carbazole-6(2H)-carboxylate (8.36 g, 20.00 mmol), Pd(OAc)2 (0.23 g, 1.00 mmol), 2-(di-tert-butylphosphino)biphenyl ligand (JohnPhos, 0.60 g, 2.00 mmol), TEA (5.6 ml, 40.00 mmol) 및 Toluene (100 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. (2H) -carboxylate (8.36 g, 20.00 mmol) and Pd (OAc) 2 (0.23 g, 1.00 mmol) in a nitrogen atmosphere. ), 2- (di-tert-butylphosphino) biphenyl ligand (JohnPhos, 0.60 g, 2.00 mmol), TEA (5.6 ml, 40.00 mmol) and Toluene (100 ml) were mixed and stirred at 110 ° C for 12 hours.

반응이 종결된 후 Toluene을 제거하고 메틸렌클로라이드로 유기층을 분리한 다음 MgSO4를 사용하여 물을 제거하였다. 유기층의 용매를 제거한 후 컬럼크로마토그래피로 정제하여 목적 화합물인 tert-butyl 4,5-dihydrobenzo[def]indeno[2,1-a]carbazole-12(11H)-carboxylate (2.06 g, 5.40 mmol, 수율 27%)과 tert-butyl 1,2-dihydrobenzo[def]indeno[1,2-b]carbazole-6(12H)-carboxylate (2.21 g, 5.80 mmol, 수율 29%)을 얻었다.After the reaction was completed, the toluene was removed, the organic layer was separated with methylene chloride, and then the water was removed using MgSO 4 . After removal of the organic layer solvent, the residue was purified by column chromatography to obtain tert-butyl 4,5-dihydrobenzo [def] indeno [2,1-a] carbazole-12 (11H) -carboxylate (2.06 g, 5.40 mmol, 27%) and tert-butyl 1,2-dihydrobenzo [def] indeno [1,2-b] carbazole-6 (12H) -carboxylate (2.21 g, 5.80 mmol, yield 29%).

tert-butyl 4,5-dihydrobenzo[def]indeno[2,1-a]carbazole-12(11H)-carboxylate의 1H-NMR : δ 1.59 (s, 9H), 2.83 (m, 4H), 4.11 (s, 2H), 7.21 (m, 3H), 7.42 (m, 1H), 7.53 (m, 1H), 7.74 (m, 2H), 7.98 (d, 1H) 1 H-NMR:? 1.59 (s, 9H), 2.83 (m, 4H), 4.11 (m, 4H) 1H), 7.74 (m, 2H), 7.98 (m, 3H), 7.42

tert-butyl 1,2-dihydrobenzo[def]indeno[1,2-b]carbazole-6(12H)-carboxylate의 1H-NMR : δ 1.59 (s, 9H), 2.83 (m, 4H), 4.11 (s, 2H), 7.22 (m, 3H), 7.44 (m, 1H), 7.51 (m, 1H), 7.74 (m, 2H), 7.89 (d, 1H)
1 H-NMR:? 1.59 (s, 9H), 2.83 (m, 4H), 4.11 (m, 4H) (s, 2H), 7.22 (m, 3H), 7.44 (m,

<단계 3> IC-15의 합성<Step 3> Synthesis of IC-15

Figure 112012086902721-pat00036
Figure 112012086902721-pat00036

질소 기류 하에서 tert-butyl 4,5-dihydrobenzo[def]indeno[2,1-a]carbazole-12(11H)-carboxylate (2.06 g, 5.40 mmol)을 THF 50 ml에 녹인 다음 0℃에서 Potassium tert-butoxide (1.81 g, 16.13 mmol) 넣고 10분 동안 교반하였다. 그리고 Iodomethane (2.29 g, 16.13 mmol)을 넣고 상온에서 12시간 동안 교반하였다. (11H) -carboxylate (2.06 g, 5.40 mmol) was dissolved in 50 ml of THF at 0 ° C., and a solution of potassium tert-butyl 4,5-dihydrobenzo [ butoxide (1.81 g, 16.13 mmol) was added thereto, followed by stirring for 10 minutes. Iodomethane (2.29 g, 16.13 mmol) was added thereto, followed by stirring at room temperature for 12 hours.

반응이 종결된 후 THF를 제거하고 메틸렌클로라이드로 유기층을 분리한 다음 MgSO4를 사용하여 물을 제거하였다. 유기층의 용매를 제거한 후 유기화합물을 Silica-gel (150 g)과 함께 Toluene 200 ml에 넣고 110℃에서 12시간을 교반하였고, filter로 silica-gel을 제거하고 Toluene을 농축하여 목적 화합물 IC-15 (1.02 g, 3.29 mmol, 수율 61%) 을 얻었다.After the reaction was completed, the THF was removed, the organic layer was separated with methylene chloride, and water was removed using MgSO 4 . After removing the solvent of the organic layer, the organic compound was added to 200 ml of toluene together with 150 g of silica gel, stirred at 110 ° C. for 12 hours, filtered to remove silica-gel, 1.02 g, 3.29 mmol, yield: 61%).

1H-NMR : δ 1.57 (s, 6H), 2.83 (m, 4H), 7.23 (m, 3H), 7.55 (m, 2H), 7.75 (m, 2H), 7.91 (d, 1H), 10.13 (s, 1H)
1 H-NMR: δ 1.57 ( s, 6H), 2.83 (m, 4H), 7.23 (m, 3H), 7.55 (m, 2H), 7.75 (m, 2H), 7.91 (d, 1H), 10.13 ( s, 1 H)

[준비예 12] IC-16의 합성[Preparation Example 12] Synthesis of IC-16

<단계 1> IC-16의 합성<Step 1> Synthesis of IC-16

Figure 112012086902721-pat00037
Figure 112012086902721-pat00037

tert-butyl 4,5-dihydrobenzo[def]indeno[2,1-a]carbazole-12(11H)-carboxylate 대신 tert-butyl 1,2-dihydrobenzo[def]indeno[1,2-b]carbazole-6(12H)-carboxylate (2.06 g, 5.40 mmol)을 사용하는 것을 제외하고는 준비예 11의 <단계 3>과 동일한 과정을 수행하여 목적화합물 IC-16 (1.08 g, 3.51 mmol, 수율 65%)을 얻었다.tert-butyl 4,5-dihydrobenzo [b] indeno [2,1-a] carbazole-12 (11H) (1.08 g, 3.51 mmol, yield 65%) was obtained by carrying out the same procedure as <Step 3> of Preparation Example 11, except that the compound (12H) -carboxylate (2.06 g, 5.40 mmol) .

1H-NMR : δ 1.57 (s, 6H), 2.83 (m, 4H), 7.24 (m, 3H), 7.51 (m, 2H), 7.72 (m, 2H), 7.93 (d, 1H), 10.08 (s, 1H)
1 H-NMR: δ 1.57 ( s, 6H), 2.83 (m, 4H), 7.24 (m, 3H), 7.51 (m, 2H), 7.72 (m, 2H), 7.93 (d, 1H), 10.08 ( s, 1 H)

[합성예 1] Inv-1의 합성[Synthesis Example 1] Synthesis of Inv-1

Figure 112012086902721-pat00038
Figure 112012086902721-pat00038

질소 기류 하에서 준비예 1에서 제조된 화합물인 IC-1 (1.07 g, 3.00 mmol), 2-bromo-6-phenylpyridine (0.84 g, 3.60 mmol), Cu powder(0.027 g, 0.40 mmol), K2CO3(0.55 g, 0.40 mmol), Na2SO4(0.57 g, 4.00 mmol) 및 nitrobenzene(100 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. (1.07 g, 3.00 mmol), 2-bromo-6-phenylpyridine (0.84 g, 3.60 mmol), Cu powder (0.027 g, 0.40 mmol), K 2 CO 3 (0.55 g, 0.40 mmol), Na 2 SO 4 (0.57 g, 4.00 mmol) and nitrobenzene (100 ml) were mixed and stirred at 190 ° C for 12 hours.

반응이 종결된 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리한 다음 MgSO4를 사용하여 물을 제거하였다. 유기층의 용매를 제거한 후 컬럼 크로마토그래피(Hexane:EA = 3:1 (v/v))로 정제하여 목적 화합물인 Inv-1 (1.23 g, 수율 80 %)을 얻었다. After the reaction was completed, the nitrobenzene was removed, the organic layer was separated with methylene chloride, and water was removed using MgSO 4 . The solvent of the organic layer was removed, and the residue was purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain the target compound Inv-1 (1.23 g, yield 80%).

GC-Mass (이론치: 511.61 g/mol, 측정치: 511 g/mol)
GC-Mass (calculated: 511.61 g / mol, measured: 511 g / mol)

[합성예 2] Inv-2의 합성[Synthesis Example 2] Synthesis of Inv-2

Figure 112012086902721-pat00039
Figure 112012086902721-pat00039

질소 기류 하에서 준비예 1에서 제조된 화합물인 IC-1 (1.07 g, 3.00 mmol)을 DMF 100 ml에 녹이고 여기에 NaH (0.11 g, 4.50 mmol)를 넣고 1시간 교반하였다. 여기에 DMF 100ml에 녹인 2-chloro-4,6-diphenyl-1,3,5-triazine (0.96 g, 3.60 mmol)을 천천히 첨가하였다. 3시간 동안 교반한 후 반응을 종료시키고 혼합물을 실리카 필터링하고 물과 메탄올로 씻은 후 용매를 제거하였다. 용매가 제거된 고체를 컬럼 크로마토그래피 (Hexane:EA = 1:1 (v/v))로 정제하여 목적 화합물인 Inv-2 (1.38 g, 수율 78 %)을 얻었다.Compound IC-1 (1.07 g, 3.00 mmol) prepared in Preparation Example 1 was dissolved in DMF (100 ml) under a nitrogen stream, and NaH (0.11 g, 4.50 mmol) was added thereto and stirred for 1 hour. 2-chloro-4,6-diphenyl-1,3,5-triazine (0.96 g, 3.60 mmol) dissolved in 100 ml of DMF was added slowly. After stirring for 3 hours, the reaction was terminated and the mixture was filtered through silica, washed with water and methanol, and then the solvent was removed. The solvent-removed solid was purified by column chromatography (Hexane: EA = 1: 1 (v / v)) to give the target compound Inv-2 (1.38 g, yield 78%).

GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)
GC-Mass (calculated: 589.23 g / mol, measured: 589 g / mol)

[합성예 3] Inv-3의 합성[Synthesis Example 3] Synthesis of Inv-3

Figure 112012086902721-pat00040
Figure 112012086902721-pat00040

2-bromo-6-phenylpyridine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine를 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-3 (1.50 g, 수율 75 %)를 얻었다. Synthesis was conducted in the same manner as in Synthesis Example 1, except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine was used instead of 2-bromo-6- -3 (1.50 g, yield 75%).

GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)
GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)

[합성예 4] Inv-4의 합성[Synthesis Example 4] Synthesis of Inv-4

Figure 112012086902721-pat00041
Figure 112012086902721-pat00041

2-bromo-6-phenylpyridine 대신 2-(4-bromophenyl)triphenylene를 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-4 (1.65 g, 수율 78 %)를 얻었다. (1.65 g, yield 78%) was obtained in the same manner as in Synthesis Example 1 except that 2- (4-bromophenyl) triphenylene was used in place of 2-bromo-6-phenylpyridine.

GC-Mass (이론치: 660.26 g/mol, 측정치: 660 g/mol)
GC-Mass (calculated: 660.26 g / mol, measured: 660 g / mol)

[합성예 5] Inv-5의 합성[Synthesis Example 5] Synthesis of Inv-5

Figure 112012086902721-pat00042
Figure 112012086902721-pat00042

2-bromo-6-phenylpyridine 대신 3-bromo-9-phenyl-9H-carbazole를 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-5 (1.37 g, 수율 76 %)를 얻었다. Inv-5 (1.37 g, yield 76%) was synthesized in the same manner as in Synthesis Example 1, except that 3-bromo-9-phenyl-9H-carbazole was used in place of 2-bromo- .

GC-Mass (이론치: 599.24 g/mol, 측정치: 599 g/mol)
GC-Mass (calculated: 599.24 g / mol, measured: 599 g / mol)

[합성예 6] Inv-6의 합성[Synthesis Example 6] Synthesis of Inv-6

Figure 112012086902721-pat00043
Figure 112012086902721-pat00043

2-bromo-6-phenylpyridine 대신 4-bromodibenzo[b,d]thiophene를 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-6 (1.22 g, 수율 75 %)를 얻었다. (1.22 g, yield 75%) as a target compound was obtained by the same method as in Synthesis Example 1, except that 4-bromodibenzo [b, d] thiophene was used in place of 2-bromo-6-phenylpyridine .

GC-Mass (이론치: 540.17 g/mol, 측정치: 540 g/mol)
GC-Mass (calculated: 540.17 g / mol, measured: 540 g / mol)

[합성예 7] Inv-7의 합성[Synthesis Example 7] Synthesis of Inv-7

Figure 112012086902721-pat00044
Figure 112012086902721-pat00044

2-chloro-4,6-diphenyl-1,3,5-triazine 대신 2-(3-bromophenyl)-4,6-diphenylpyrimidine를 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-7 (1.53 g, 수율 78 %)을 얻었다. 2-chloro-4,6-diphenyl-1,3,5-triazine was used instead of 2- (3-bromophenyl) -4,6-diphenylpyrimidine Inv-7 (1.53 g, yield 78%).

GC-Mass (이론치: 664.28 g/mol, 측정치: 664 g/mol)
GC-Mass (theory: 664.28 g / mol, measurement: 664 g / mol)

[합성예 8] Inv-8의 합성[Synthesis Example 8] Synthesis of Inv-8

Figure 112012086902721-pat00045
Figure 112012086902721-pat00045

IC-1 과 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 IC-2와 2-chloro-4,6-diphenylpyrimidine를 각각 사용한 것을 제외하고는, 상기 합성예 2와 동일한 방법으로 합성하여 목적 화합물인 Inv-8 (1.25 g, 수율 71 %)를 얻었다. Except that IC-2 and 2-chloro-4,6-diphenylpyrimidine were used in place of IC-1 and 2-chloro-4,6-diphenyl-1,3,5- To obtain the target compound Inv-8 (1.25 g, yield 71%).

GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)
GC-Mass (calculated: 588.23 g / mol, measured: 588 g / mol)

[합성예 9] Inv-9의 합성[Synthesis Example 9] Synthesis of Inv-9

Figure 112012086902721-pat00046
Figure 112012086902721-pat00046

IC-1과 2-bromo-6-phenylpyridine 대신 IC-2와 2-bromo-4,6-diphenylpyridine를 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-9 (1.41 g, 수율 80 %)를 얻었다. Synthesis Example 1 was repeated except that IC-2 and 2-bromo-4,6-diphenylpyridine were used in place of IC-1 and 2-bromo-6-phenylpyridine, g, yield: 80%).

GC-Mass (이론치: 587.24 g/mol, 측정치: 587 g/mol)
GC-Mass (calculated: 587.24 g / mol, measured: 587 g / mol)

[합성예 10] Inv-10의 합성[Synthesis Example 10] Synthesis of Inv-10

Figure 112012086902721-pat00047
Figure 112012086902721-pat00047

IC-1 대신 IC-2를 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-10 (1.50 g, 수율 75 %)를 얻었다. Synthesis Example 3 was repeated except that IC-2 was used instead of IC-1 to obtain the target compound Inv-10 (1.50 g, yield 75%).

GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)
GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)

[합성예 11] Inv-11의 합성[Synthesis Example 11] Synthesis of Inv-11

Figure 112012086902721-pat00048
Figure 112012086902721-pat00048

IC-1과 2-bromo-6-phenylpyridine 대신 IC-2와 2-(3-bromo-5-methylphenyl)-4,6-diphenyl-1,3,5-triazine 를 각각 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-11 (1.61 g, 수율 79 %)를 얻었다. Except that IC-2 and 2- (3-bromo-5-methylphenyl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 2-bromo-6-phenylpyridine, respectively. Was synthesized in the same manner as in Synthesis Example 1 to obtain Inv-11 (1.61 g, yield 79%) as a target compound.

GC-Mass (이론치: 679.27 g/mol, 측정치: 679 g/mol)
GC-Mass (calculated: 679.27 g / mol, measured: 679 g / mol)

[합성예 12] Inv-12의 합성[Synthesis Example 12] Synthesis of Inv-12

Figure 112012086902721-pat00049
Figure 112012086902721-pat00049

IC-1과 2-bromo-6-phenylpyridine 대신 IC-2와 2-(3-bromo-5-(trifluoromethyl)phenyl)-4,6-diphenyl-1,3,5-triazine를 각각 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-12 (1.58 g, 수율 72 %)를 얻었다. Except that IC-2 and 2- (3-bromo-5- (trifluoromethyl) phenyl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 2-bromo-6- Was synthesized in the same manner as in Synthesis Example 1 to obtain Inv-12 (1.58 g, yield 72%) as a target compound.

GC-Mass (이론치: 733.25 g/mol, 측정치: 733 g/mol)
GC-Mass (733.25 g / mol, measured: 733 g / mol)

[합성예 13] Inv-13의 합성[Synthesis Example 13] Synthesis of Inv-13

Figure 112012086902721-pat00050
Figure 112012086902721-pat00050

IC-1 대신 IC-3을 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-13 (1.32 g, 수율 75 %)을 얻었다. Synthesis was conducted in the same manner as in Synthesis Example 1, except that IC-3 was used instead of IC-1 to obtain the target compound Inv-13 (1.32 g, yield 75%).

GC-Mass (이론치: 587.24 g/mol, 측정치: 587 g/mol)
GC-Mass (calculated: 587.24 g / mol, measured: 587 g / mol)

[합성예 14] Inv-14의 합성[Synthesis Example 14] Synthesis of Inv-14

Figure 112012086902721-pat00051
Figure 112012086902721-pat00051

IC-1 대신 IC-3을 사용한 것을 제외하고는, 상기 합성예 2와 동일한 방법으로 합성하여 목적 화합물인 Inv-14 (1.50 g, 수율 75 %)를 얻었다. Synthesis Example 2 was repeated except that IC-3 was used instead of IC-1 to obtain Inv-14 (1.50 g, yield 75%) as a target compound.

GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)
GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)

[합성예 15] Inv-15의 합성[Synthesis Example 15] Synthesis of Inv-15

Figure 112012086902721-pat00052
Figure 112012086902721-pat00052

IC-1 대신 IC-3을 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-15 (1.69 g, 수율 76 %)를 얻었다. Was synthesized in the same manner as in Synthesis Example 3, except that IC-3 was used in place of IC-1 to obtain the target compound Inv-15 (1.69 g, yield 76%).

GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)
GC-Mass (741.29 g / mol, measured: 741 g / mol)

[합성예 16] Inv-16의 합성[Synthesis Example 16] Synthesis of Inv-16

Figure 112012086902721-pat00053
Figure 112012086902721-pat00053

IC-1 대신 IC-3을 사용한 것을 제외하고는, 상기 합성예 7과 동일한 방법으로 합성하여 목적 화합물인 Inv-16 (1.57 g, 수율 71 %)를 얻었다. (1.57 g, yield 71%) was obtained by the same method as Synthesis Example 7, except that IC-3 was used instead of IC-1.

GC-Mass (이론치: 740.29 g/mol, 측정치: 740 g/mol)
GC-Mass (calculated: 740.29 g / mol, measured: 740 g / mol)

[합성예 17] Inv-17의 합성[Synthesis Example 17] Synthesis of Inv-17

Figure 112012086902721-pat00054
Figure 112012086902721-pat00054

IC-1 대신 IC-4를 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-17 (1.45 g, 수율 75 %)를 얻었다. Synthesis Example 3 was repeated except that IC-4 was used instead of IC-1 to obtain the target compound Inv-17 (1.45 g, yield 75%).

GC-Mass (이론치: 643.27 g/mol, 측정치: 643 g/mol)
GC-Mass (calculated: 643.27 g / mol, measured: 643 g / mol)

[합성예 18] Inv-18의 합성[Synthesis Example 18] Synthesis of Inv-18

Figure 112012086902721-pat00055
Figure 112012086902721-pat00055

IC-2 대신 IC-4를 사용한 것을 제외하고는, 상기 합성예 11과 동일한 방법으로 합성하여 목적 화합물인 Inv-18 (1.65 g, 수율 73 %)를 얻었다. Was synthesized in the same manner as in Synthesis Example 11, except that IC-4 was used in place of IC-2 to obtain the target compound Inv-18 (1.65 g, yield 73%).

GC-Mass (이론치: 755.30 g/mol, 측정치: 755 g/mol)
GC-Mass (calculated: 755.30 g / mol, measured: 755 g / mol)

[합성예 19] Inv-19의 합성[Synthesis Example 19] Synthesis of Inv-19

Figure 112012086902721-pat00056
Figure 112012086902721-pat00056

IC-1과 2-bromo-6-phenylpyridine 대신 IC-4와 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 각각 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-19 (1.84 g, 수율 75 %)를 얻었다. Except that IC-4 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine were used in place of IC-1 and 2-bromo-6-phenylpyridine, respectively. (Inv-19, 1.84 g, yield 75%) was obtained by synthesizing the same method as Synthesis Example 1.

GC-Mass (이론치: 817.32 g/mol, 측정치: 817 g/mol)
GC-Mass (theory: 817.32 g / mol, measured: 817 g / mol)

[합성예 20] Inv-20의 합성[Synthesis Example 20] Synthesis of Inv-20

Figure 112012086902721-pat00057
Figure 112012086902721-pat00057

IC-1 대신 IC-5를 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-20 (1.37 g, 수율 78 %)를 얻었다. (Inv-20) (1.37 g, yield 78%) was obtained in the same manner as in Synthesis Example 1, except that IC-5 was used instead of IC-1.

GC-Mass (이론치: 587.24 g/mol, 측정치: 587 g/mol)
GC-Mass (calculated: 587.24 g / mol, measured: 587 g / mol)

[합성예 21] Inv-21의 합성[Synthesis Example 21] Synthesis of Inv-21

Figure 112012086902721-pat00058
Figure 112012086902721-pat00058

IC-1 대신 IC-5를 사용한 것을 제외하고는, 상기 합성예 2와 동일한 방법으로 합성하여 목적 화합물인 Inv-21 (1.50 g, 수율 75 %)를 얻었다. Was synthesized in the same manner as in Synthesis Example 2, except that IC-5 was used in place of IC-1 to obtain the target compound Inv-21 (1.50 g, yield 75%).

GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)
GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)

[합성예 22] Inv-22의 합성[Synthesis Example 22] Synthesis of Inv-22

Figure 112012086902721-pat00059
Figure 112012086902721-pat00059

IC-1 대신 IC-5를 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-22 (1.78 g, 수율 80 %)를 얻었다. Synthesis Example 3 was repeated except that IC-5 was used instead of IC-1 to obtain Inv-22 (1.78 g, yield 80%) as a target compound.

GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)
GC-Mass (741.29 g / mol, measured: 741 g / mol)

[합성예 23] Inv-23의 합성[Synthesis Example 23] Synthesis of Inv-23

Figure 112012086902721-pat00060
Figure 112012086902721-pat00060

IC-1 대신 IC-5를 사용한 것을 제외하고는, 상기 합성예 7과 동일한 방법으로 합성하여 목적 화합물인 Inv-23 (1.64 g, 수율 74 %)를 얻었다. Was synthesized in the same manner as in Synthesis Example 7, except that IC-5 was used instead of IC-1 to obtain the target compound Inv-23 (1.64 g, yield 74%).

GC-Mass (이론치: 740.29 g/mol, 측정치: 740 g/mol)
GC-Mass (calculated: 740.29 g / mol, measured: 740 g / mol)

[합성예 24] Inv-24의 합성[Synthesis Example 24] Synthesis of Inv-24

Figure 112012086902721-pat00061
Figure 112012086902721-pat00061

IC-1 대신 IC-6을 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-24 (1.50 g, 수율 78 %)를 얻었다. Synthesis Example 3 was repeated except that IC-6 was used in place of IC-1 to obtain the target compound Inv-24 (1.50 g, yield 78%).

GC-Mass (이론치: 643.27 g/mol, 측정치: 643 g/mol)
GC-Mass (calculated: 643.27 g / mol, measured: 643 g / mol)

[합성예 25] Inv-25의 합성[Synthesis Example 25] Synthesis of Inv-25

Figure 112012086902721-pat00062
Figure 112012086902721-pat00062

IC-2 대신 IC-6을 사용한 것을 제외하고는, 상기 합성예 11과 동일한 방법으로 합성하여 목적 화합물인 Inv-25 (1.65 g, 수율 73 %)를 얻었다. Synthesis was carried out in the same manner as in Synthesis Example 11, except that IC-6 was used instead of IC-2 to obtain the object compound Inv-25 (1.65 g, yield 73%).

GC-Mass (이론치: 755.30 g/mol, 측정치: 755 g/mol)
GC-Mass (calculated: 755.30 g / mol, measured: 755 g / mol)

[합성예 26] Inv-26의 합성[Synthesis Example 26] Synthesis of Inv-26

Figure 112012086902721-pat00063
Figure 112012086902721-pat00063

IC-1과 2-bromo-6-phenylpyridine 대신 IC-6과 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 각각 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-26 (1.74 g, 수율 71 %)를 얻었다. Except that IC-6 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 2-bromo-6-phenylpyridine, respectively. Synthesis was conducted in the same manner as in Synthesis Example 1 to obtain Inv-26 (1.74 g, yield 71%) as a target compound.

GC-Mass (이론치: 817.32 g/mol, 측정치: 817 g/mol)
GC-Mass (theory: 817.32 g / mol, measured: 817 g / mol)

[합성예 27] Inv-27의 합성[Synthesis Example 27] Synthesis of Inv-27

Figure 112012086902721-pat00064
Figure 112012086902721-pat00064

IC-1과 2-bromo-6-phenylpyridine 대신 IC-7과 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole 을 각각 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-27 (1.65 g, 수율 73 %)를 얻었다. Except that IC-7 and 3-bromo-9- (4,6-diphenyl-1,3,5-triazin-2-yl) -9H-carbazole were used in place of IC-1 and 2-bromo-6- Was synthesized in the same manner as in Synthesis Example 1 to obtain Inv-27 (1.65 g, yield 73%) as a target compound.

GC-Mass (이론치: 754.28 g/mol, 측정치: 754 g/mol)
GC-Mass (calculated: 754.28 g / mol, measured: 754 g / mol)

[합성예 28] Inv-28의 합성[Synthesis Example 28] Synthesis of Inv-28

Figure 112012086902721-pat00065
Figure 112012086902721-pat00065

IC-1과 2-bromo-6-phenylpyridine 대신 IC-7과 (4-bromophenyl)diphenylborane 을 각각 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-28 (1.43 g, 수율 80 %)를 얻었다. Except that IC-7 and (4-bromophenyl) diphenylborane were used in place of IC-1 and 2-bromo-6-phenylpyridine, respectively, to obtain the target compound Inv-28 (1.43 g, Yield: 80%).

GC-Mass (이론치: 598.26 g/mol, 측정치: 598 g/mol)
GC-Mass (theory: 598.26 g / mol, measured: 598 g / mol)

[합성예 29] Inv-29의 합성[Synthesis Example 29] Synthesis of Inv-29

Figure 112012086902721-pat00066
Figure 112012086902721-pat00066

IC-1과 2-bromo-6-phenylpyridine 대신 IC-7과 (4-bromophenyl)diphenylphosphine 을 각각 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-29 (1.41 g, 수율 76 %)를 얻었다. 29 (1.41 g, yield) was synthesized in the same manner as in Synthesis Example 1 except that IC-7 and (4-bromophenyl) diphenylphosphine were used in place of IC-1 and 2-bromo- Yield: 76%).

GC-Mass (이론치: 618.22 g/mol, 측정치: 618 g/mol)
GC-Mass (theory: 618.22 g / mol, measured: 618 g / mol)

[합성예 30] Inv-30의 합성[Synthesis Example 30] Synthesis of Inv-30

Figure 112012086902721-pat00067
Figure 112012086902721-pat00067

IC-1과 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 IC-7과 (4-chlorophenyl)triphenylsilane 을 사용한 것을 제외하고는, 상기 합성예 2와 동일한 방법으로 합성하여 목적 화합물인 Inv-30 (1.56 g, 수율 75 %)를 얻었다. Synthesis was carried out in the same manner as in Synthesis Example 2 except that IC-7 and (4-chlorophenyl) triphenylsilane were used instead of IC-1 and 2-chloro-4,6-diphenyl-1,3,5- The compound Inv-30 (1.56 g, yield 75%) was obtained.

GC-Mass (이론치: 692.26 g/mol, 측정치: 692 g/mol)
GC-Mass (calculated: 692.26 g / mol, measured: 692 g / mol)

[합성예 31] Inv-31의 합성[Synthesis Example 31] Synthesis of Inv-31

Figure 112012086902721-pat00068
Figure 112012086902721-pat00068

IC-1 대신 IC-7를 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-31 (1.50 g, 수율 75 %)를 얻었다. Was synthesized in the same manner as in Synthesis Example 3, except that IC-7 was used instead of IC-1 to obtain the target compound Inv-31 (1.50 g, yield 75%).

GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)
GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)

[합성예 32] Inv-32의 합성[Synthesis Example 32] Synthesis of Inv-32

Figure 112012086902721-pat00069
Figure 112012086902721-pat00069

IC-1 대신 IC-10을 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-32 (1.51 g, 수율 76 %)를 얻었다. Synthesis Example 3 was repeated except that IC-10 was used instead of IC-1 to obtain the target compound Inv-32 (1.51 g, yield 76%).

GC-Mass (이론치: 665.28 g/mol, 측정치: 665 g/mol)
GC-Mass (calculated: 665.28 g / mol, measured: 665 g / mol)

[합성예 33] Inv-33의 합성[Synthesis Example 33] Synthesis of Inv-33

Figure 112012086902721-pat00070
Figure 112012086902721-pat00070

IC-1과 2-bromo-6-phenylpyridine 대신 IC-10과 2-(3-bromo-5-methylphenyl)-4,6-diphenyl-1,3,5-triazine 를 각각 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-33 (1.63 g, 수율 80 %)를 얻었다. Except that IC-10 and 2- (3-bromo-5-methylphenyl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 2-bromo-6-phenylpyridine, respectively. Was synthesized in the same manner as in Synthesis Example 1 to obtain Inv-33 (1.63 g, yield 80%) as a target compound.

GC-Mass (이론치: 679.27 g/mol, 측정치: 679 g/mol)
GC-Mass (calculated: 679.27 g / mol, measured: 679 g / mol)

[합성예 34] Inv-34의 합성[Synthesis Example 34] Synthesis of Inv-34

Figure 112012086902721-pat00071
Figure 112012086902721-pat00071

IC-1과 2-bromo-6-phenylpyridine 대신 IC-10과 2-(3-bromo-5-(trifluoromethyl)phenyl)-4,6-diphenyl-1,3,5-triazine를 각각 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-12 (1.65 g, 수율 75 %)를 얻었다. Except that IC-10 and 2- (3-bromo-5- (trifluoromethyl) phenyl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 2-bromo-6- Was synthesized in the same manner as in Synthesis Example 1 to obtain Inv-12 (1.65 g, yield 75%) as a target compound.

GC-Mass (이론치: 733.25 g/mol, 측정치: 733 g/mol)
GC-Mass (733.25 g / mol, measured: 733 g / mol)

[합성예 35] Inv-35의 합성[Synthesis Example 35] Synthesis of Inv-35

Figure 112012086902721-pat00072
Figure 112012086902721-pat00072

IC-1 대신 IC-11을 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-35 (1.78 g, 수율 80 %)를 얻었다. Synthesis Example 3 was repeated except that IC-11 was used instead of IC-1 to obtain Inv-35 (1.78 g, yield 80%) as a target compound.

GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)
GC-Mass (741.29 g / mol, measured: 741 g / mol)

[합성예 36] Inv-36의 합성[Synthesis Example 36] Synthesis of Inv-36

Figure 112012086902721-pat00073
Figure 112012086902721-pat00073

IC-1 대신 IC-11을 사용한 것을 제외하고는, 상기 합성예 7과 동일한 방법으로 합성하여 목적 화합물인 Inv-16 (1.573g, 수율 78 %)를 얻었다. (1.573 g, yield 78%) was obtained in the same manner as in Synthesis Example 7, except that IC-11 was used instead of IC-1.

GC-Mass (이론치: 740.29 g/mol, 측정치: 740 g/mol)
GC-Mass (calculated: 740.29 g / mol, measured: 740 g / mol)

[합성예 37] Inv-37의 합성[Synthesis Example 37] Synthesis of Inv-37

Figure 112012086902721-pat00074
Figure 112012086902721-pat00074

IC-1 대신 IC-8을 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-37 (1.67 g, 수율 75 %)를 얻었다. Was synthesized in the same manner as in Synthesis Example 3, except that IC-8 was used instead of IC-1 to obtain the target compound Inv-37 (1.67 g, yield 75%).

GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)
GC-Mass (741.29 g / mol, measured: 741 g / mol)

[합성예 38] Inv-38의 합성[Synthesis Example 38] Synthesis of Inv-38

Figure 112012086902721-pat00075
Figure 112012086902721-pat00075

IC-1과 2-bromo-6-phenylpyridine 대신 IC-8과 2-(3-bromo-5-methylphenyl)-4,6-diphenyl-1,3,5-triazine를 각각 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-38 (1.61 g, 수율 71 %)를 얻었다. Except that IC-8 and 2- (3-bromo-5-methylphenyl) -4,6-diphenyl-1,3,5-triazine were used in place of IC-1 and 2-bromo-6-phenylpyridine, respectively. Synthesis Example 1 was repeated to obtain Inv-38 (1.61 g, yield 71%) as a target compound.

GC-Mass (이론치: 755.30 g/mol, 측정치: 755 g/mol)
GC-Mass (calculated: 755.30 g / mol, measured: 755 g / mol)

[합성예 39] Inv-39의 합성[Synthesis Example 39] Synthesis of Inv-39

Figure 112012086902721-pat00076
Figure 112012086902721-pat00076

IC-1과 2-bromo-6-phenylpyridine 대신 IC-4와 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 각각 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-39 (1.84 g, 수율 75 %)를 얻었다. Except that IC-4 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine were used in place of IC-1 and 2-bromo-6-phenylpyridine, respectively. (Inv-39, 1.84 g, yield 75%) was obtained in the same manner as in Synthesis Example 1.

GC-Mass (이론치: 817.32 g/mol, 측정치: 817 g/mol)
GC-Mass (theory: 817.32 g / mol, measured: 817 g / mol)

[합성예 40] Inv-40의 합성[Synthesis Example 40] Synthesis of Inv-40

Figure 112012086902721-pat00077
Figure 112012086902721-pat00077

IC-1 대신 IC-9을 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-40 (1.67 g, 수율 75 %)를 얻었다. Synthesis Example 3 was repeated except that IC-9 was used instead of IC-1 to obtain the target compound Inv-40 (1.67 g, yield 75%).

GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)
GC-Mass (741.29 g / mol, measured: 741 g / mol)

[합성예 41] Inv-41의 합성[Synthesis Example 41] Synthesis of Inv-41

Figure 112012086902721-pat00078
Figure 112012086902721-pat00078

IC-1 대신 IC-9를 사용한 것을 제외하고는, 상기 합성예 7과 동일한 방법으로 합성하여 목적 화합물인 Inv-41 (1.64 g, 수율 74 %)를 얻었다. Synthesis was conducted in the same manner as in Synthesis Example 7, except that IC-9 was used instead of IC-1 to obtain the target compound Inv-41 (1.64 g, yield 74%).

GC-Mass (이론치: 740.29 g/mol, 측정치: 740 g/mol)
GC-Mass (calculated: 740.29 g / mol, measured: 740 g / mol)

[합성예 42] Inv-42의 합성[Synthesis Example 42] Synthesis of Inv-42

Figure 112012086902721-pat00079
Figure 112012086902721-pat00079

IC-1 대신 IC-12를 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-42 (1.78 g, 수율 80 %)를 얻었다. Synthesis Example 3 was repeated except that IC-12 was used in place of IC-1 to obtain the target compound Inv-42 (1.78 g, yield 80%).

GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)
GC-Mass (741.29 g / mol, measured: 741 g / mol)

[합성예 43] Inv-43의 합성[Synthesis Example 43] Synthesis of Inv-43

Figure 112012086902721-pat00080
Figure 112012086902721-pat00080

IC-1 대신 IC-13을 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-43 (1.58 g, 수율 71 %)를 얻었다. Synthesis was conducted in the same manner as in Synthesis Example 3, except that IC-13 was used in place of IC-1 to obtain the target compound Inv-43 (1.58 g, yield 71%).

GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)
GC-Mass (741.29 g / mol, measured: 741 g / mol)

[합성예 44] Inv-44의 합성[Synthesis Example 44] Synthesis of Inv-44

Figure 112012086902721-pat00081
Figure 112012086902721-pat00081

IC-1 대신 IC-14을 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-44 (1.76 g, 수율 79 %)를 얻었다. The procedure of Synthesis Example 3 was repeated except that IC-14 was used instead of IC-1 to obtain the target compound Inv-44 (1.76 g, yield 79%).

GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)
GC-Mass (741.29 g / mol, measured: 741 g / mol)

[합성예 45] Inv-45의 합성[Synthesis Example 45] Synthesis of Inv-45

Figure 112012086902721-pat00082
Figure 112012086902721-pat00082

IC-1 대신 IC-15을 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-45 (1.48 g, 수율 80 %)를 얻었다. Synthesis Example 3 was repeated except that IC-15 was used in place of IC-1 to obtain the target compound Inv-45 (1.48 g, yield 80%).

GC-Mass (이론치: 616.26 g/mol, 측정치: 616 g/mol)
GC-Mass (theory: 616.26 g / mol, measured: 616 g / mol)

[합성예 46] Inv-46의 합성[Synthesis Example 46] Synthesis of Inv-46

Figure 112012086902721-pat00083
Figure 112012086902721-pat00083

IC-1 대신 IC-16을 사용한 것을 제외하고는, 상기 합성예 3과 동일한 방법으로 합성하여 목적 화합물인 Inv-46 (1.42 g, 수율 77 %)를 얻었다. Synthesis Example 3 was repeated except that IC-16 was used instead of IC-1 to obtain the target compound Inv-46 (1.42 g, yield 77%).

GC-Mass (이론치: 616.26 g/mol, 측정치: 616 g/mol)
GC-Mass (theory: 616.26 g / mol, measured: 616 g / mol)

[합성예 47] Inv-47의 합성[Synthesis Example 47] Synthesis of Inv-47

Figure 112012086902721-pat00084
Figure 112012086902721-pat00084

2-bromo-6-phenylpyridine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine를 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-47 (1.58 g, 수율 71 %)를 얻었다. Synthesis was conducted in the same manner as in Synthesis Example 1, except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine was used instead of 2-bromo-6- -47 (1.58 g, yield 71%).

GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)
GC-Mass (741.29 g / mol, measured: 741 g / mol)

[합성예 48] Inv-48의 합성[Synthesis Example 48] Synthesis of Inv-48

Figure 112012086902721-pat00085
Figure 112012086902721-pat00085

2-bromo-6-phenylpyridine 대신 2-(3'-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine를 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-48 (1.56 g, 수율 70%)를 얻었다. Synthesis was carried out in the same manner as in Synthesis Example 1, except that 2- (3'-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine was used instead of 2-bromo-6- To obtain Inv-48 (1.56 g, yield 70%) as a target compound.

GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)
GC-Mass (741.29 g / mol, measured: 741 g / mol)

[합성예 49] Inv-49의 합성[Synthesis Example 49] Synthesis of Inv-49

Figure 112012086902721-pat00086
Figure 112012086902721-pat00086

2-bromo-6-phenylpyridine 대신 2-(3'-bromobiphenyl-4-yl)-4,6-diphenyl-1,3,5-triazine를 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-49 (1.56 g, 수율 70%)를 얻었다. Synthesis was carried out in the same manner as in Synthesis Example 1, except that 2- (3'-bromobiphenyl-4-yl) -4,6-diphenyl-1,3,5-triazine was used in place of 2-bromo-6- To obtain the object compound Inv-49 (1.56 g, yield 70%).

GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)
GC-Mass (741.29 g / mol, measured: 741 g / mol)

[합성예 50] Inv-50의 합성[Synthesis Example 50] Synthesis of Inv-50

Figure 112012086902721-pat00087
Figure 112012086902721-pat00087

2-bromo-6-phenylpyridine 대신 N-(biphenyl-4-yl)-N-(4-bromophenyl)biphenyl-4-amine를 사용한 것을 제외하고는, 상기 합성예 1과 동일한 방법으로 합성하여 목적 화합물인 Inv-50 (1.69 g, 수율 75%)를 얻었다. Was synthesized in the same manner as in Synthesis Example 1, except that N- (biphenyl-4-yl) -N- (4-bromophenyl) biphenyl-4-amine was used in place of 2-bromo- Inv-50 (1.69 g, yield 75%).

GC-Mass (이론치: 753.31 g/mol, 측정치: 753 g/mol)
GC-Mass (calculated: 753.31 g / mol, measured: 753 g / mol)

[실시예 1] 유기 EL 소자의 제작[Example 1] Production of organic EL device

합성예 1에서 합성된 화합물 Inv-1을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후, 하기와 같이 녹색 유기 EL 소자를 제조하였다.The compound Inv-1 synthesized in Synthesis Example 1 was subjected to high-purity sublimation purification by a conventionally known method, and then a green organic EL device was produced as follows.

ITO (Indium tin oxide)가 1500 Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면, 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음, UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.Glass substrate coated with ITO (Indium tin oxide) thin film with thickness of 1500 Å was washed with distilled water ultrasonic wave. After the distilled water was washed, it was ultrasonically washed with a solvent such as isopropyl alcohol, acetone, or methanol, dried, transferred to a UV OZONE cleaner (Power sonic 405, Hoshin Tech), and then the substrate was cleaned using UV for 5 minutes The substrate was transferred to a vacuum evaporator.

상기와 같이 준비된 ITO 투명 전극 위에, 합성예 1의 화합물 Mat-1를 호스트로 이용하여, m-MTDATA(60 nm) / TCTA(80 nm) / 화합물 Inv-1 + 10 % Ir(ppy)3(300nm) / BCP(10 nm) / Alq3(30 nm) / LiF(1 nm) / Al(200 nm) 순으로 적층하여 유기 EL 소자를 제작하였다.M-MTDATA (60 nm) / TCTA (80 nm) / Compound Inv-1 + 10% Ir (ppy) 3 (80 nm) was formed on the ITO transparent electrode prepared above using the compound Mat- (300 nm) / BCP (10 nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm).

m-MTDATA, TCTA, Ir(ppy)3, CBP 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir (ppy) 3 , CBP and BCP are as follows.

Figure 112012086902721-pat00088
Figure 112012086902721-pat00088

Figure 112012086902721-pat00089

Figure 112012086902721-pat00089

[실시예 2 ~ 50] 유기 EL 소자의 제조[Examples 2 to 50] Preparation of organic EL device

실시예 1에서 발광층 형성시 발광 호스트 물질로서 사용된 화합물 Inv-1 대신 합성예 2 내지 50에서 각각 합성된 화합물 (Inv-2 ~ Inv-50)을 사용하는 것을 제외하고는, 실시예 1과 동일하게 수행하여 유기 EL 소자를 제조하였다.
Except that the compounds (Inv-2 to Inv-50) synthesized in Synthesis Examples 2 to 50 were used in place of the compound Inv-1 used as a light emitting host material in the formation of the light emitting layer in Example 1, To prepare an organic EL device.

[비교예 1] 유기 EL 소자의 제작[Comparative Example 1] Fabrication of organic EL device

발광층 형성시 발광 호스트 물질로서 사용된 화합물 Inv-1 대신 CBP를 사용하는 것을 제외하고는, 실시예 1과 동일하게 수행하여 녹색 유기 EL 소자를 제작하였다. CBP의 구조는 하기와 같다.A green organic EL device was fabricated in the same manner as in Example 1, except that CBP was used instead of the compound Inv-1 used as a luminescent host material in the formation of the light emitting layer. The structure of CBP is as follows.

Figure 112012086902721-pat00090

Figure 112012086902721-pat00090

[실험예][Experimental Example]

실시예 1 내지 50, 및 비교예 1 에서 각각 제조된 녹색 유기 EL 소자에 대하여, 전류밀도 10 mA/㎠에서의 구동전압, 전류효율 및 발광 피크를 측정하였고, 그 결과를 하기 표 1에 나타내었다.The driving voltage, current efficiency and emission peak at a current density of 10 mA / cm 2 were measured for the green organic EL devices manufactured in Examples 1 to 50 and Comparative Example 1, respectively, and the results are shown in the following Table 1 .

샘플Sample 호스트Host 구동 전압
(V)
Driving voltage
(V)
전류효율
(cd/A)
Current efficiency
(cd / A)
실시예 1Example 1 Inv-1Inv-1 6.556.55 41.541.5 실시예 2Example 2 Inv-2Inv-2 6.496.49 41.041.0 실시예 3Example 3 Inv-3Inv-3 6.536.53 41.341.3 실시예 4Example 4 Inv-4Inv-4 6.556.55 40.940.9 실시예 5Example 5 Inv-5Inv-5 6.506.50 41.041.0 실시예 6Example 6 Inv-6Inv-6 6.526.52 41.241.2 실시예 7Example 7 Inv-7Inv-7 6.516.51 41.541.5 실시예 8Example 8 Inv-8Inv-8 6.446.44 40.840.8 실시예 9Example 9 Inv-9Inv-9 6.506.50 41.641.6 실시예 10Example 10 Inv-10Inv-10 6.456.45 41.341.3 실시예 11Example 11 Inv-11Inv-11 6.586.58 40.840.8 실시예 12Example 12 Inv-12Inv-12 6.606.60 41.041.0 실시예 13Example 13 Inv-13Inv-13 6.556.55 41.241.2 실시예 14Example 14 Inv-14Inv-14 6.506.50 41.741.7 실시예 15Example 15 Inv-15Inv-15 6.656.65 42.142.1 실시예 16Example 16 Inv-16Inv-16 6.606.60 41.541.5 실시예 17Example 17 Inv-17Inv-17 6.626.62 41.941.9 실시예 18Example 18 Inv-18Inv-18 6.506.50 41.741.7 실시예 19Example 19 Inv-19Inv-19 6.456.45 40.540.5 실시예 20Example 20 Inv-20Inv-20 6.526.52 41.541.5 실시예 21Example 21 Inv-21Inv-21 6.506.50 40.940.9 실시예 22Example 22 Inv-22Inv-22 6.606.60 41.541.5 실시예 23Example 23 Inv-23Inv-23 6.456.45 41.841.8 실시예 24Example 24 Inv-24Inv-24 6.526.52 40.840.8 실시예 25Example 25 Inv-25Inv-25 6.556.55 41.241.2 실시예 26Example 26 Inv-26Inv-26 6.586.58 41.541.5 실시예 27Example 27 Inv-27Inv-27 6.616.61 42.142.1 실시예 28Example 28 Inv-28Inv-28 6.506.50 41.641.6 실시예 29Example 29 Inv-29Inv-29 6.556.55 41.041.0 실시예 30Example 30 Inv-30Inv-30 6.506.50 41.341.3 실시예 31Example 31 Inv-31Inv-31 6.606.60 40.840.8 실시예 32Example 32 Inv-32Inv-32 6.556.55 41.541.5 실시예 33Example 33 Inv-33Inv-33 6.556.55 41.241.2 실시예 34Example 34 Inv-34Inv-34 6.506.50 41.741.7 실시예 35Example 35 Inv-35Inv-35 6.656.65 42.142.1 실시예 36Example 36 Inv-36Inv-36 6.606.60 41.341.3 실시예 37Example 37 Inv-37Inv-37 6.626.62 40.940.9 실시예 38Example 38 Inv-38Inv-38 6.506.50 41.241.2 실시예 39Example 39 Inv-39Inv-39 6.456.45 40.640.6 실시예 40Example 40 Inv-40Inv-40 6.526.52 41.041.0 실시예 41Example 41 Inv-41Inv-41 6.506.50 40.740.7 실시예 42Example 42 Inv-42Inv-42 6.606.60 41.141.1 실시예 43Example 43 Inv-43Inv-43 6.456.45 41.041.0 실시예 44Example 44 Inv-44Inv-44 6.526.52 40.540.5 실시예 45Example 45 Inv-45Inv-45 6.556.55 40.940.9 실시예 46Example 46 Inv-46Inv-46 6.506.50 42.042.0 실시예 47Example 47 Inv-47Inv-47 6.516.51 41.941.9 실시예 48Example 48 Inv-48Inv-48 6.506.50 41.841.8 실시예 49Example 49 Inv-49Inv-49 6.456.45 42.142.1 실시예 50Example 50 Inv-50Inv-50 6.456.45 41.541.5 비교예 1Comparative Example 1 CBPCBP 6.936.93 38.238.2

실험 결과, 본 발명에 따른 화학식 1로 표시되는 화합물(화합물 Inv-1 내지 Inv-50)을 발광층의 호스트 물질로 사용하는 실시예 1 내지 50에서 각각 제조된 유기 EL 소자는 종래 CBP를 사용하는 비교예 1의 유기 EL 소자보다 전류효율 및 구동전압 면에서 우수한 성능을 나타내는 것을 확인할 수 있었다.As a result of the experiment, the organic EL devices prepared in Examples 1 to 50, respectively using the compounds represented by the formula (1) (compounds Inv-1 to Inv-50) according to the present invention as the host material of the light emitting layer, It was confirmed that the organic EL device of Example 1 exhibited superior performance in current efficiency and driving voltage.

이상을 통해 본 발명의 바람직한 실시예에 대하여 설명하였지만, 본 발명은 이에 한정되는 것이 아니고 특허청구범위와 발명의 상세한 설명의 범위 안에서 여러 가지로 변형하여 실시하는 것이 가능하고 이 또한 발명의 범주에 속하는 것은 당연하다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed embodiments, but, on the contrary, It is natural.

Claims (8)

하기 화학식 1로 표시되는 화합물:
[화학식 1]
Figure 112015015446358-pat00091

상기 식에서,
R6 및 R7 또는 R7 및 R8 중 적어도 하나는 하기 화학식 2와 축합 고리를 형성하고,
[화학식 2]
Figure 112015015446358-pat00092

X는 N(Ar2), 및 C(Ar3)(Ar4)로 구성된 군으로부터 선택되고,
R1 내지 R12 는 서로 같거나 또는 상이하고, 각각 독립적으로 수소, 또는 페닐이고,
Ar1 및 Ar2는 서로 같거나 또는 상이하며, 각각 독립적으로 C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C6~C60의 아릴실릴기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, 및 C6~C60의 아릴아민기로 구성된 군으로부터 선택되며,
Ar3 및 Ar4는 서로 같거나 또는 상이하며, 각각 독립적으로 C1-C40의 알킬기 또는 페닐기이며,
상기 C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C6~C60의 아릴보론기, C6~C40의 아릴실릴기, C6~C60의 아릴포스핀기, 및 C6~C60의 아릴아민기는, 각각 독립적으로 할로겐, C1~C40의 알킬기, C6~C40의 아릴기, 및 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군으로부터 선택된 하나 이상의 치환기로 치환될 수 있다.
A compound represented by the following formula (1):
[Chemical Formula 1]
Figure 112015015446358-pat00091

In this formula,
R 6 and R 7 or R 7 and R 8, at least one of which is to form the formula (2) with a condensed ring,
(2)
Figure 112015015446358-pat00092

X is selected from the group consisting of N (Ar 2), and C (Ar 3) (Ar 4 ),
R 1 to R 12 are the same or different and each independently hydrogen or phenyl,
Ar 1 and Ar 2 are the same or different and each independently represents a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 6 to C 60 arylsilyl group, a C 6 to C A C 6 to C 60 arylphosphine group, and a C 6 to C 60 arylamine group,
Ar 3 and Ar 4 are the same or different and are each independently a C 1 -C 40 alkyl or phenyl group,
The C 1 ~ C 40 alkyl group, C 6 ~ C 60 aryl group, nuclear atoms aryl of from 5 to 60 heteroaryl group, C 6 ~ C group 60 arylboronic of, C 6 ~ C 40 aryl silyl group, C of of 6 ~ C 60 aryl phosphine group, and a C 6 ~ group is an aryl amine of the C 60, each independently of halogen, C 1 ~ C 40 alkyl group, C 6 ~ C 40 aryl group, and the number of nuclear atoms of 5 to 40 of the A heteroaryl group, and a heteroaryl group.
제1항에 있어서, 상기 화학식 1로 표시되는 화합물은 하기 화학식 3 내지 화학식 6 중 어느 하나로 표시되는 것을 특징으로 하는 화합물:
[화학식 3]
Figure 112015015446358-pat00093

[화학식 4]
Figure 112015015446358-pat00094

[화학식 5]
Figure 112015015446358-pat00095

[화학식 6]
Figure 112015015446358-pat00096

상기 식에서,
X, R1 내지 R12, Ar1 내지 Ar4은 각각 제1항에서 정의된 바와 동일하다.
The compound according to claim 1, wherein the compound represented by the formula (1) is represented by any one of the following formulas (3) to (6)
(3)
Figure 112015015446358-pat00093

[Chemical Formula 4]
Figure 112015015446358-pat00094

[Chemical Formula 5]
Figure 112015015446358-pat00095

[Chemical Formula 6]
Figure 112015015446358-pat00096

In this formula,
X, R 1 to R 12 , and Ar 1 to Ar 4 are the same as defined in claim 1, respectively.
제 1항에 있어서, 상기 화학식 1로 표시되는 화합물은 하기 화학식으로 표시되는 화합물 군 중 어느 하나로 표시되는 것을 특징으로 하는 화합물:
Figure 112015015446358-pat00099

상기 식에서,
R1 내지 R12, Ar1 내지 Ar4은 각각 제1항에서 정의된 바와 동일하다.
The compound according to claim 1, wherein the compound represented by the formula (1) is represented by any one of the following compounds:
Figure 112015015446358-pat00099

In this formula,
R 1 to R 12 and Ar 1 to Ar 4 are the same as defined in claim 1, respectively.
삭제delete 삭제delete 제 1항에 있어서,
상기 X는 N(Ar2)이며, Ar1 내지 Ar2는 서로 같거나 또는 상이하며, 각각 독립적으로 하기 치환체 군으로부터 선택되는 것을 특징으로 하는 화합물:
Figure 112015015446358-pat00098
The method according to claim 1,
Wherein X is N (Ar 2 ), Ar 1 to Ar 2 are the same or different and are each independently selected from the following Substituent group:
Figure 112015015446358-pat00098
양극, 음극, 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며, 상기 1층 이상의 유기물층 중 적어도 하나는 제 1항 내지 제3항, 제6항 중 어느 한 항에 기재된 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자. A cathode, and at least one organic layer interposed between the anode and the cathode, wherein at least one of the one or more organic layers includes at least one organic layer selected from the group consisting of those described in any one of claims 1 to 3, Wherein the organic compound is a compound represented by the following formula (1). 제7항에 있어서, 상기 화합물을 포함하는 적어도 하나의 유기물층은 정공 주입층, 정공 수송층 및 발광층으로 구성된 군으로부터 선택되는 것을 특징으로 하는 유기 전계 발광 소자.The organic electroluminescent device according to claim 7, wherein at least one organic compound layer containing the compound is selected from the group consisting of a hole injection layer, a hole transport layer and a light emitting layer.
KR1020120118638A 2012-10-24 2012-10-24 Organic compounds and organic electro luminescence device using the same KR101556819B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020120118638A KR101556819B1 (en) 2012-10-24 2012-10-24 Organic compounds and organic electro luminescence device using the same
PCT/KR2013/007955 WO2014065501A1 (en) 2012-10-24 2013-09-04 Organic compound and organic electroluminescent element comprising same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120118638A KR101556819B1 (en) 2012-10-24 2012-10-24 Organic compounds and organic electro luminescence device using the same

Publications (2)

Publication Number Publication Date
KR20140052499A KR20140052499A (en) 2014-05-07
KR101556819B1 true KR101556819B1 (en) 2015-10-01

Family

ID=50544846

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120118638A KR101556819B1 (en) 2012-10-24 2012-10-24 Organic compounds and organic electro luminescence device using the same

Country Status (2)

Country Link
KR (1) KR101556819B1 (en)
WO (1) WO2014065501A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9299181B2 (en) * 2013-08-28 2016-03-29 Qualcomm Incorporated Target independent stenciling in graphics processing
KR101641410B1 (en) * 2014-02-20 2016-07-20 주식회사 두산 Organic light-emitting compound and organic electroluminescent device comprising the same
KR102307359B1 (en) * 2014-12-22 2021-10-05 솔루스첨단소재 주식회사 Organic light-emitting compound and organic electroluminescent device using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011099451A1 (en) 2010-02-12 2011-08-18 新日鐵化学株式会社 Organic electroluminescent element
WO2011116866A1 (en) 2010-03-24 2011-09-29 Merck Patent Gmbh Polymers of 8,9-dihydrobenzo[def]carbazole and their use as organic semiconductors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011099451A1 (en) 2010-02-12 2011-08-18 新日鐵化学株式会社 Organic electroluminescent element
WO2011116866A1 (en) 2010-03-24 2011-09-29 Merck Patent Gmbh Polymers of 8,9-dihydrobenzo[def]carbazole and their use as organic semiconductors

Also Published As

Publication number Publication date
KR20140052499A (en) 2014-05-07
WO2014065501A1 (en) 2014-05-01

Similar Documents

Publication Publication Date Title
KR101560674B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101601355B1 (en) Novel organic compounds and organic electro luminescence device comprising the same
KR101601356B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101571591B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102508486B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101609027B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20150061174A (en) Organic compounds and organic electro luminescence device comprising the same
KR101561338B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20180022189A (en) Organic compounds and organic electro luminescence device comprising the same
KR20170075524A (en) Organic compounds and organic electro luminescence device comprising the same
KR101641409B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20150008678A (en) Organic compounds and organic electro luminescence device comprising the same
KR101556823B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101577104B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20140038060A (en) Organic compound and organic electroluminescent device comprising the same
KR20140082550A (en) Organic compounds and organic electro luminescence device comprising the same
KR101576570B1 (en) Organic compounds and organic electro luminescence device comprising the same
JP6228979B2 (en) Organic light emitting compound and organic electroluminescent device using the same
KR101556819B1 (en) Organic compounds and organic electro luminescence device using the same
KR101548040B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101622809B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101634849B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102507368B1 (en) Organic compound and organic electroluminescent device using the same
KR20160079548A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR101612154B1 (en) Organic compounds and organic electro luminescence device comprising the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee